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Chapter 1 
1 Introduction 
1.1 Glycosylation of Biopharmaceutical Products 
The application of proteins in the biopharmaceutical field is rapidly increasing. In the 
last decade one in four of all new drugs developed and placed on the market have been 
biopharmaceuticals. In general, biopharmaceuticals are therapeutics produced by modern 
biotechnology, respectively “produced by means other than direct extraction from a native 
(non-engineered) biological source” [1, 2]. Since the 1990s the term “biopharmaceutical” 
includes drugs based on proteins, nucleic acids and engineered stem and other therapeutic 
cell lines [3]. It is estimated that in the next decade approximately 30% of newly licensed 
drugs will be based on antibody products [4-7]. Protein based drugs, such as antibodies, 
undergo a variety of different posttranslational modifications (PTM) as proteolytic 
processing, disulfide bond formation, sulfatation, amidation, glycosylation and 
carboxylation. Thereof, glycosylation represents one of the most characteristic as well as 
most complex PTM of biopharmaceuticals. Studies have shown that more than 50% of all 
proteins are glycosylated [8, 9]. Monoclonal antibodies for instance are mainly based on 
immunoglobuline G (IgG) and therefore are mostly glycosylated.  
Glycosylation has influence on the protein folding process, chemical and physical 
stability, the physiological life time as well as many biological processes on protein 
and /or cellular basis. Therefore, eludicating the glycosylation patterns of 
pharmaceutically employed glycoproteins is of high importance in terms of product 
quality and therapeutic efficacy [4, 10]. The same protein can be glycosylated differently, 
related to factors as enzyme activity, monomer availability or protein dwelling time in 
Golgi and endoplasmic reticulum. Hence, even the PTM of native molecules in their 
natural environment undergoes various modifications. In cultured cells the type and 
content of cultivation media, including pH and the availability of nutrients and precursor 
molecules may have influence on the glycosylation as well as diverse cell lines. In 
particular, cells from different organisms can create extremely diverse glycan species as 
those synthesized by mammalian cells (including different linkages, glycan monomer 
compositions and structures). Thus, the complex PTM process, as glycosylation, has to be 
considered starting at the early stage of biopharmaceutical development, till the 
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administration to patients. The efficacy and safety for the patients has to be ensured, to 
avoid reduced efficacy or even undesirable immunogenicity [11, 12].  
Glycosylation is highly complex. The amino acid sequence of glycoproteins exhibits 
one or more possible glycosylation sites with at least one covalently attached 
monosaccharide or oligosaccharide. However, not every potential glycosylation site is 
strictly occupied. In human proteins the most abundant sites are at asparagines (N-linked 
glycosylation in a motif of Asparagine-X-serine/threonine) and certain serine or threonine 
residues (O-linked glycosylation). The focus of glycosylation analysis in the presented 
work is set on N-glycosylation. N-glycosylation shows a high degree of 
microheterogeneity due to the complex pool of monosaccharides, differences in branching 
and antennae length. The different monosaccharides are very similar in structure, 
composition and molecular weight. The basis of all N-glycans is a core structure of two 
N-acetylglycosamines linked to three mannose residues. This trimannosyl core can be 
linked to further glycan monomers at the individual mannose residues, hereby 2-5 
antennae can be formed [13]. According to their structure (monomer type, order and 
linkages), they are classified into three main groups. The most abundant are high-
mannose and complex types. The high mannose type contains between five and nine 
mannose residues which are linked to the core structure. The complex type is often 
branched containing different glycan monomers in addition to mannose. Thereof, five 
typical complex-type N-glycans in monoclonal antibodies (G0F, G1F, G2F, A1F and A2F) 
[14, 15] were applied in this work. The structures are depicted in CFG (Consortium for 
Functional Glycomics) nomenclature in Fig. 1. The last one, not as common as the former 
types, is defined as hybrid type and combines the high mannose and the complex 
structure. 
 
Fig. 1: Five complex type N-glycans abundant in many therapeutic antibodies. The glycan structures are 
displayed according to the CFG nomenclature: ■: N-Acetylgalactosamine, : Mannose,  
: Galactose, ▲: Fucose, ♦: N-Acetylneuraminic Acid 
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The analysis of glycosylation is challenging due to the described high macro- and 
microheterogeneity of N-linked glycans. Thus, the development of methods for the 
analysis of closely related glycoforms (i.e. including structural glycan isomers) is of high 
interest in the pharmaceutical industry as well as in the academic area. There are several 
techniques to encode this complex process. The most common techniques are described in 
several standard bioanalytics and biochemistry books as well as in a rapidly increasing 
number of review articles about glycoprotein analysis [16-20].  
Glycosylation analysis can be performed on glycoproteins, glycopeptides and released 
glycans. The separation of glycoproteins is frequently performed with sodium dodecyl 
sulfate – polyacrylamide gel electrophoresis (SDS-PAGE), often in combination with 
isoelectric focusing in 2-dimensional gel electrophoresis. Carbohydrate-specific lectins 
can be used to sensitively detect and characterize the glycoforms of blotted proteins after 
gel electrophoresis. Alternatively, the selectivity of lectins is employed in lectin affinity 
chromatography [21, 22]. Almost complete or at least partial resolution of glycoforms can 
be obtained via capillary zone electrophoresis (CZE). However, the characterization of 
glycoforms is hardly possible. Thus, mass spectrometric characterization of glycoproteins 
can be performed additionally applying a matrix-assisted laser desorption/ionization time-
of-flight (MALDI-TOF) instrument.  
Glycopeptide analysis enables the identification of site-specific glycosylation. For this 
purpose the glycoprotein is digested with specific (e.g. trypsin, Asp-N, Lys-C, or Glu-C) 
or nonspecific endoproteases (e.g. pronase) to obtain glycopeptides carrying individual 
glycosylation sites. Afterwards the peptides are separated, commonly by high 
performance liquid chromatography (HPLC) on reversed or normal phase. The glycan 
structures can be characterized by fragmentation experiments by electrospray 
ionization/mass spectrometric detection (ESI-MS/MS) using frequently collision-induced 
dissociation (CID) and/or electron transfer dissociation (ETD), via the exact mass 
difference of the glycan-released peptide to the glycopeptide.  
However, both glycoprotein and glycopeptide analysis are hardly capable to analyze 
structural glycan modifications, minor changes of monomer composition or structural 
isomers. Furthermore, glycan analysis is universal for most glycoproteins, whereas 
methods for glycoprotein and glycopeptides might need modification (i.e. sample pre-
treatment, suitable enzymes, separation methods etc.) depending on the individual 
glycoprotein. Therefore, glycan characterization based on glycoprotein-glycans is of high 
importance in biopharmaceutical and biological research [23]. The analytical strategies 
for glycoprotein-glycans range from different types of capillary electrophoresis (CE) and 
several types of liquid chromatography (LC) on the one hand to different optical and mass 
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spectrometric detection methods on the other hand [17, 24, 25]. The glycans are either 
enzymatically or chemically released from the protein or peptide moiety [26]. N-glycans 
are effectively and most commonly released by glycopeptide N-glycosidase (PNGase F). 
To enhance the efficiency of glycan cleavage the glycoproteins are often denatured by 
reduction with mercaptoethanol/SDS or dithiothreitol and then alkylated for example with 
iodoacetamide. Afterwards, the glycans can be separated by chromatographic or 
electromigrative techniques. Common chromatographic methods are hydrophilic 
interaction chromatography (HILIC) [27, 28], high-pH anion exchange chromatography 
(HPAEC) [29-32], reversed phase (RP)-HPLC and porous graphitic carbon (PGC)-LC 
[33, 34]. Electromigrative separation is mainly performed as CE next to microchip 
systems [35-39].  
The CE technique is widespread in the biopharmaceutical field [17, 40-44]. Major 
strategies are CZE and capillary sieving electrophoresis (CSE, term is used according to 
IUPAC nomenclature [45]). LC and CE techniques often include the labeling of the 
reducing end of released glycans to enable separation or/and the following optical 
(fluorescence or UV) or MS [19, 46] detection. MS detection can be performed using ESI 
or MALDI. MALDI-TOF is suitable for neutral as well as charged glycans; however, 
fragmentation of fragile glycan compounds is likely [47]. ESI-MS is the method of choice 
in combination with most glycan separation techniques. The detection of charged, often 
labeled glycans in ESI-MS is more sensitive than MALDI and the extent of acidic glycan 
fragmentation is much lower. Both MALDI-TOF and ESI-MS provide information on 
glycan composition by accurate mass. More detailed information about glycan monomer 
linkages and branching can be obtained for native glycans using MS/MS fragmentation or 
repeated analysis after application of selective exoglycosidases.  
Capillary electrophoresis is widespread in the pharmaceutical industry especially for 
routine analysis of glycosylation using CSE with laser induced fluorescence (LIF) 
detection. These systems provide fast analysis combined with high resolving power. 
Especially for a fast examination of glycosylation modifications these systems are well 
suited.  
Glycans need derivatization prior to CE-LIF analysis to enable fluorescence detection 
and to enhance glycan separation [46]. Well studied ionic labeling reagents of common 
CSE-LIF methods are the negatively charged 8-aminopyrene-1,3,6-trisulfonic acid 
(APTS) [48-51], the 8-aminonaphthalene-1,3,6-trisulfonic acid [52-54] or 2-
aminobenzoic acid [55, 56]. Cationic labeling reagents like the in HPLC commonly used 
2-aminobenzamid can also be applied. However, the negative charge of attached sialic 
acids can form neutral or negatively charged glycans, which should be taken into account 
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during method development. Thus, negatively charged labels are generally preferred in 
CE for glycan analysis (enabling the analysis of uncharged and negatively charged 
glycans). Thereof, the trisulfonated APTS-label is one of the most abundant labels in 
routine CSE-LIF glycan analysis and was applied in this work. It provides fast analyte 
migration and high separation efficiency based on the analyte’s size-to-charge ratio 
including the separation of structural isomers. Furthermore, commercially available 
analysis kits promote the widespread application. A first-hand identification or 
characterization of unknown glycan species by optical detection is not possible. Since 
standards are often not available or very expensive, alternative strategies are required. For 
this purpose CZE-MS is well suited because it combines the high separation efficiency of 
CE with accurate mass detection to identify glycan species. In this work APTS-labeled 
glycans as for CSE-LIF was used to enable the identification of LIF signals by CE-MS.  
The following two paragraphs describe the theoretical and practical aspects of these 
two techniques. 
1.1.1 Capillary Electrophoresis 
CE is one of the most efficient techniques to separate ionic compounds. The principle 
of CE is based on the migration of ionic compounds in an electric field, whereby the 
analytes are separated with respect to their size-to-charge ratio. The term “Capillary 
Electrophoresis” involves different separation techniques such as CZE or CSE. CZE is the 
most common technique, often simply termed CE. Based on mobility differences the 
analyte ions are separated in capillaries filled with a homogeneous electrolyte. In CSE the 
capillaries are filled with high viscosity or polymerized electrolytes, frequently termed 
“capillary gel electrophoresis” (CGE). Here, the molecule size and structure have more 
influence on separation due to the sieving effect of the (partly) polymerized electrolyte.  
The separation technique of choice for CE-MS is CZE [19, 57-61] because CZE 
enables superior separation efficiency based on the analyte’s size-to-charge-ratio and is 
performed in MS-compatible background electrolyte (BGE) systems. Separation is 
mainly influenced by the electrophoretic mobility of the analytes in combination with the 
electroosmotic flow (EOF). The electrophoretic mobility is dependent on the charge of 
the analyte (influenced by the pH of the electrolyte), the analyte’s size and the 
electrolyte’s viscosity (temperature dependent). 
The EOF is the motion of liquid created by the migration of net charge in the electrical 
double layer between capillary wall and electrolyte solution induced by an applied 
voltage at the capillary ends. The EOF velocity (vEOF) is influenced by the applied field 
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strength E, the Zeta potential ζ (inversely proportional to the ionic strength of the BGE), 
the dielectric constant ε and the viscosity η of the electrolyte solution (equation 1). 
(1)  ηπ
ζε
××
××=
4
vEOF
E
 
The electroosmotic mobility (µEOF) is described by equation 2: 
(2) 
EEOF
EOFv
4
 =××
×= ηπ
ζεμ   
Furthermore, the velocity of the EOF is a function of the temperature and of added 
organic solvents such as methanol. Both parameters affect the viscosity of the electrolyte 
and thereby the mobility of the EOF and the analytes. Alternatively, the EOF can be 
modified by capillary coatings as described in the next paragraph. 
Capillary Coatings 
The EOF velocity and direction can be modified by several static or dynamic capillary 
coatings, independent of the BGE’s pH [62-64]. Hereby the EOF is enhanced, reduced, or 
even reversed, dependent on the coating’s surface. In this work neutral coatings are 
applied to avoid creating an EOF at pH 4.0. The method is employed with reversed 
polarity (anodic detection), thus, the EOF runs toward the capillary inlet. In this way the 
method would be incompatible with MS-coupling because a suction into the capillary is 
created which affects the electrospray signal and the CE current. Consequently, 
hydrophilic nonionic polymers can be adsorbed, cross-linked or covalently bonded to the 
fused silica surface to significantly reduce or fully suppress the EOF.  
1.1.2 Analysis of Negatively Charged Glycans 
The CE-MS methods presented here are applied to negatively charged glycans 
(naturally by the presence of sialic acids or induced by a negatively charged label). There 
are two different principles of CE to selectively separate negatively charged analytes like 
APTS-labeled glycans.  
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(a) 
 
(b) 
Fig. 2: CE separation techniques to separate negatively charged glycans by capillary electrophoresis/mass 
spectrometry. More details are described in the text. 
The techniques are schematically displayed in Fig. 2, where: 
(a) A negative potential is applied to the capillary inlet (reverse polarity) whereby the 
negatively charged glycans migrate to the anodic outlet. This technique requires 
an EOF close to zero. In combination with mass spectrometers a complete 
suppression of the EOF is required. The EOF can be suppressed using a BGE 
< pH 2, so almost all silanol residues are protonated. Alternatively, a neutral 
coating of the capillary inner wall avoids the generation of an EOF, as mentioned 
before.  
(b) A positive potential is applied to the capillary inlet (normal polarity). A strong 
EOF (BGE at alkaline pH) transports the negatively charged glycans contrary to 
their inherent mobility to the cathodic outlet.  
1.1.3 Mass Spectrometry 
Common mass spectrometry methods applied in glycan analysis are based on ESI and 
MALDI techniques [65-67]. In this work capillary electrophoresis is used with online 
ESI-TOF-MS. Beside TOF instruments, other mass analyzers with medium or high 
resolution (R ≥ 5.000) and fast scan rates are applicable. 
Regarding the coupling with CE instruments, MS detectors with a grounded source 
and the electrospray potential applied to the entrance of the MS are clearly advantageous. 
These preconditions lead to a simpler method development, since the separation voltage 
can be applied independently to the electrospray process.  
The next paragraph describes the principles of electrospray ionization and TOF 
detection techniques. 
  
Introduction 
 
8 
Electrospray Ionization 
Electrospray ionization is a very efficient and soft ionization technique [68-71] which 
has made it very popular in analysis of bio-molecules. Solvated ions are transferred from 
liquid to gas phase in an electric field by desolvation with little energy transfer to the 
molecule. Between the MS entrance and the sprayer tip an electrospray potential is 
applied and by varying the polarity either positive or negative charges are generated. The 
solvated analytes are electrosprayed at the tip of a conductive sprayer needle as a fine 
aerosol, assisted by nitrogen flow. Contrary to MALDI, the formation of multiply charged 
ions is possible and enables the detection of small as well as large molecules like proteins. 
The amount of charges depends on the number of possible charge carriers and their 
positions in the molecule structure, e.g. APTS-labeled N-glycans create mostly doubly 
and triply charged ions. For CE-MS coupling a coaxial sheath-liquid (SL) interface is 
frequently used [72]. The SL closes the electric circuit for the inner capillary 
electrophoretic separation. Additionally, the SL, containing a mixture of organic solvents 
(e.g. 2-propanol or methanol) and water, supports the low flow in CE (nL/min range) to 
enable a stable spray and a good desorption of the formed droplets. Additives in the SL 
can support the ionization process, e.g. volatile acidic components like formic or acetic 
acid. During the electrospray process the charge density of the formed droplets increases 
while the solvents evaporate. The formation of free analyte ions in the gas phase is 
explained by two basic models [73]: the charged residue model of Dole or Röllgen’s 
“single ion in droplet theory” and the ion evaporation model of Iribane and Thomson. 
1.1.4 Time-of-flight mass spectrometry 
The principle of MS is the separation of gas phase ions according to their mass-to-
charge (m/z) ratios in an electric field. One efficient mass spectrometer is the TOF mass 
spectrometer. The basic principle of mass determination is based on very precise time-of-
flight measurements of ions accelerated in a high vacuum. After the generation of gas 
phase ions in the ion source as described in the latter paragraph, the mass analyzer 
separates the generated ions according to their m/z ratios. The detector records at all times 
the intensity of the ions as a function of their m/z ratio, based on this the evaluation unit 
creates a mass spectrum. There are various techniques of ion generation and mass 
separation [74].  
The generated ions are focused and transferred to the flight tube by several lense 
arrangements. Hybrid QTOF mass spectrometers include an analytical quadrupole and a 
gas filled quadrupole acting as a collision cell in front of the time-of-flight tube. Hence, 
selective ion fragmentation can be carried out for the identification of unknown 
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substances or the verification of putative sum formulas. Finally the ions are pulsed 
orthogonally accelerated into the field-free tube with a single acceleration voltage of 
several kV. Depending on their m/z ratio the different ion velocities arise. During the 
flight in the field-free space the ions are separated. At the upper end of the tube a reflector 
directs the ions back to the detector. The accurate m/z ratio is precisely determined out of 
the fixed flight path s (1-4 m), the flight time t (from a few to 100 µs), the elementary 
charge e and the acceleration voltage U (equation 3).  
(3) 
2
22
s
tUe
z
m ⋅⋅⋅=    
The main advantages of TOF-MS are the high resolution (up to 10,000) and the high 
accuracy of mass determination (up to 1 ppm) in addition to a large dynamic range and 
high speed detection. The instrument used in this work is equipped with an analogue to 
digital converter (ADC) enabling a discrimination free measurement of the isotopic 
pattern. 
The coupling of CE with an ESI-TOF mass analyzer is an ideal combination for the 
analysis of anions in complex matrices. The fast, high resolving detector is able to 
separately detect substances with very similar migration times and can identify them by 
accurate mass.  
1.2 Aims and Scope 
The aim of this work is to establish CE-MS methods for glycan identification and 
characterization in the biopharmaceutical field. State of the art for routine as well as high-
throughput glycan analysis is CSE-LIF using 8-aminopyrene-1,3,6-trisulfonic acid 
(APTS) labeled glycans. Since first-hand identification of unknown glycans is not 
possible by optical detection an alternative method is required. CE-TOF-MS presents a 
powerful and selective orthogonal technique to ease the identification. Glycan analysis by 
CSE-LIF provides high separation efficiency (i.e. separation of structural isomers) and 
excellent detection sensitivity for APTS-labeled glycans. Thus, the request for CE-TOF-
MS is set on high level. CE-MS methods with high separation efficiencies similar to CSE 
are rare in this field [19, 59, 75-77] (manuscript 1). 
CE-MS method development was primarily based on the objective to separate 
structural glycan isomers. Therefore, the two structural isoforms of G1F were chosen as a 
reference. Furthermore, the methods were supposed to be as comparable as possible to 
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common CSE-LIF methods. Thus, this work was focused on APTS-labeled glycans, due 
to their direct compatibility to common CSE-LIF systems. The applied separation voltage 
is favored to be in reverse mode with anodic detection, to obtain the same migration 
direction as CSE and enables a direct comparability of glycan patterns obtained by CSE-
LIF and CE-MS (manuscript 3). 
In this work two different CE-MS methods for the identification of glycans are 
presented. Besides an acidic BGE system, with the favored anodic detection, an 
alternative alkaline BGE system with cathodic detection and hence reverse migration 
order is proposed. Both methods have been optimized and validated for the application to 
biopharmaceutical samples. The methods’ comparability with standard CSE-LIF systems 
has been evaluated (manuscript 2 and 3). 
Finally the reduced detection sensitivity of TOF-MS compared to highly sensitive 
fluorescence detection was to be solved, since the determination of minor glycan species 
found by LIF detection is of importance. An online CE-LIF-MS setup has been 
implemented. Additionally, an in-line solid phase extraction (SPE)-CE-MS setup has been 
developed to concentrate the analytes after injection, prior to separation (manuscript 4). 
   11 
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0.1 Manuscript 1 
 
Capillary electrophoresis/mass spectrometry relevant to pharmaceutical 
and biotechnological applications 
M. Pioch, S.-C. Bunz, C. Neusüß 
Electrophoresis 33(11), 1517-30 (2012) 
 
 
 
The manuscript reviews the actual developments of CE/MS in the biopharmaceutical 
field. The glycosylation analysis is presented based on glycoproteins, -peptides as well as 
released glycans. Recent approaches and applications for carbohydrate analysis are 
presented starting from 2006.  
 
 
 
Candidate’s work: Literature research and review preparation of introduction 
parts and preparation of the carbohydrate section. 
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Review
Capillary electrophoresis/mass
spectrometry relevant to pharmaceutical
and biotechnological applications
Advanced analytical techniques play a crucial role in the pharmaceutical and biotechno-
logical ﬁeld. In this context, capillary electrophoresis/mass spectrometry (CE/MS) has
attracted attention due to efﬁcient and selective separation in combination with powerful
detection allowing identiﬁcation and detailed characterization. Method developments and
applications of CE/MS have been focused on questions not easily accessible by liquid chro-
matography/mass spectrometry (LC/MS) as the analysis of intact proteins, carbohydrates,
and various smallmolecules, including peptides.Here, recent approaches and applications
of CE/MS relevant to (bio)pharmaceuticals are reviewed and discussed to show actual de-
velopments and future prospects. Based on other reviews on related subjects covering
large parts of previous works, the paper is focused on general ideas and contributions of
the last 2 years; for the analysis of glycans, the period is extended back to 2006.
Keywords:
Capillary electrophoresis/mass spectrometry / Glycosylation / Intact protein anal-
ysis / Pharmaceutical applications DOI 10.1002/elps.201200030
1 Introduction
Pharmaceutical development and production require ade-
quate analytical techniques. Especially in research and devel-
opment as well as in all aspects of the strongly growing bio-
pharmaceutical sector, advanced characterization tools are re-
quired. Mass spectrometry plays a crucial role as it allows the
rapid and sensitive characterization based on (accurate) mass
measurement or tandem mass spectrometry [1–6]. However,
separation is generally required in order to gain analyte ca-
pacity, matrix removal, and/or to avoid ionization suppres-
sion. Liquid chromatography primarily in the reversed-phase
mode is mainly used as a separation technique due to its ro-
bust and reproducible set-up, its wide applicability based on
Correspondence: Dr. Christian Neusu¨ß, Chemistry Department,
Aalen University, Beethovenstr. 1, 73430 Aalen, Germany
E-mail: christian.neusuess@htw-aalen.de
Fax:+ 07361-576442399
Abbreviations: 2-AA, 2-aminobenzoic acid; 2-AB, 2-
aminobenzamid; AGP, alpha-1-acid glycoprotein; AHL,
N-acyl-L-homoserine-lactonase; APTS, 9-aminopyrene-1,3,6-
trisulfonic acid; CSE, capillary sieving electrophoresis;
DMA-EpyM, acrylamide-pyrrolidine methacrylate; DS, dex-
tran sulfate; EPO, erythropoietin; EtOH, ethanol; FA, formic
acid; GH, growth hormone; Hac, acetic acid; hGH, human
growth hormone; IPA, isopropyl alcohol; MeOH, methanol;
NH4Ac, ammonium acetate; PVS, poly(vinyl sulfonic acid);
rhGH, recombinant human growth hormone; rhIFN-,
interferon--1a; rMAb, recombinant monoclonal antibody;
SOD, superoxide dismutase
hydrophobic interaction, and its straightforward combination
with electrospray ionization mass spectrometry [7–9]. How-
ever, electrophoretic separation is widespread for the analysis
of biopolymers, for example, for DNA sequencing or protein
analysis by SDS-PAGE [10, 11]. The capillary dimension al-
lows zone electrophoretic separation and, thus, applications
like the separation of stereoisomers where CE is mostly ap-
plied in the pharmaceutical industry [12]. More important,
direct coupling to mass spectrometry is feasible in this way.
CE/MS has developed in recent years toward a routinely ap-
plicable technique [13–17]. Many pharmaceutical companies
have invested in this technique in the last years.
Generally CE is beneﬁcial with respect to separation efﬁ-
ciency and short analysis time [18,19]. The injection of small
sample amount in CE (compared to LC) is an advantage in
certain cases, whereas, it also leads to limited concentration
sensitivity which is a general drawback of CE. However, in
the pharmaceutical context, sufﬁcient and high concentrated
samples are often available. The main reason applying CE
and CE/MS is its selectivity even if additives like sieving ma-
trices (“gels”) or nonvolatile BGE additives like cyclodextrins
(separation of enantiomers) interfere with the analytes in the
ESI process (and lead to contamination of the MS). Thus,
almost all applications of CE/MS in the pharmaceutical area
are based on CZE separation. CZE/MS is suitable to analyze
all kind of ionic molecules. Both acidic and basic analytes are
accessible, separating and detecting the analytes as cations or
anions. Small molecules as well as amino acids or peptides
Colour Online: See the article online to view Fig. 1 in colour.
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have been analyzed in this way [17, 20, 21]. Intact protein
analysis has developed to a major application of CE/MS in
the last years [22,23]. Appropriate coating of the capillary wall
facilitates efﬁcient separation among proteins, protein iso-
forms, or matrix (e.g. salts) [24–32].
Glycosylation studies are of great interest in the pharma-
ceutical area [33, 34]. Many biopharmaceuticals are glycopro-
teins, for example, antibodies are generally glycosylated. As
glycosylation inﬂuences the protein folding, protein stability,
and the biological activity, protein glycosylation proﬁling is
important in the ﬁeld of product development and quality
control [35]. Glycosylation analysis can be performed on in-
tact protein level, on the peptide level, i.e. after proteolytic
digestion of the protein, or on the level of the glycans. All
three approaches can be performed using CE/MS. However,
CE/MS is especially suitable for the analysis of intact proteins
[22] and the analysis of glycans [36] due to the separation
selectivity of CE based on charge/size ratio of the analytes.
Glycopeptides are primarily analyzed by LC/MS, however, the
separation of glycopeptides from nonglycosylated peptides by
CE/MS can be an advantage [37].
Here we summarize recent publications in the method
development and the application of CE/MS relevant in the
pharmaceutical context. Several application ﬁelds of CE/MS
in the pharmaceutical area are included; however, we focus
on the analysis of intact proteins and the analysis of glycosy-
lation. As several reviews cover parts of this subject mainly
studies published in the last 2 years are summarized here, for
the analysis of glycans the period is extended back to 2006.
2 Technical aspects
2.1 Capillary electrophoresis
CZE is the key mode of capillary-based electromigration tech-
niques when coupled to mass spectrometry. However, MEKC
[38,39], CGE or CSE [40,41], CEC [42–44] have been coupled
to MS in the last years. Nevertheless, if any electromigration
technique is expected to be routinely applied to pharmaceuti-
cal applications, CZE/MS is the method of choice. This is ob-
vious from the summary of the recent papers as presented in
the following parts of this review article. Nonaqueous CE/MS
(NACE/MS) is an interesting alternative to achieve a certain
selectivity or to enable the analysis of hardly water-soluble
analytes [45]. A further increase in applications of NACE/MS
also in the pharmaceutical context is expected. Any CE instru-
ment can be used for CE/MS as long as the capillary can be
led out of the instrument and the software accepts external
grounding of the capillary outlet.
2.2 Interfaces
Electrospray ionization is the technique of choice for the
transfer of the ions from the end of the separation capil-
lary into the mass spectrometer. The most robust and most
widely used approach is the use of a coaxial sheath-liquid in-
terface[46]. CE/MS method development is straightforward
if the interface is on ground and the inlet of the MS is put
onto high voltage for ESI. By means of the used sheath liquid
additional acidity (especially for intact protein application)
or basicity can be introduced to improve the ionization ef-
ﬁciency. The relevant interface parameters are listed in the
Tables 1–3 of this review.
Nanoelectrospray is of interest due to increased sensi-
tivity, however, mostly lacks robustness or is useful for cer-
tain applications only. An interesting approach is based on
the development of a porous sprayer [47]. A recently devel-
oped prototype has been applied for peptide analysis [48, 49]
and intact protein analysis [50]. S/N ratio has been reported
to be increased by more than one order of magnitude for
small model proteins. The versatility and ability for routine
and robust application, however, still needs to be shown.
A miniaturization of the sheath-liquid interface is an inter-
esting alternative [51, 52]. Maxwell et al. applied such an
interface to the analysis of glycans [53]. However, a thor-
ough comparison to alternative other interfaces remains to be
performed.
APCI or APPI might in certain cases be an option, if the
BGE contains nonvolatile constituents [54, 55] or additional
selectivity (nonionic analytes) is required [56]; however, ESI
is usually by far more efﬁcient for ionic analytes as usually
analyzed by CE.
2.3 Mass spectrometry
The mass spectrometer provides the required selectivity
and mass accuracy for each application. All kinds of mass
analyzers can be used for small molecule analysis by CE/MS.
Tandem mass spectrometry can be beneﬁcial for peptide se-
quencing, structure analysis, or the gain of selectivity, while
high resolution provides also enhanced selectivity and is the
basis for mass accuracy, potentially enabling the determina-
tion of the elemental composition. The concepts, instrumen-
tal considerations, and applications of CE/TOFMS have been
recently reviewed [57].
Ion traps are often used for the analysis of peptides and
small pharmaceutical substances [9, 12, 15], while TOFMS
was used due to its higher mass accuracy [8]. Small pharma-
ceutical substances in blood serum were analyzed by TOFMS
to provide enhanced selectivity [11, 14]. Common mass an-
alyzers in the ﬁeld of CE/MS for glycan analysis are TOF,
QTOF, and ion trap instruments.
In case of the analysis of intact proteins mostly TOFMS
was employed, providing the necessary mass range for the
macromolecules and the short spectrum acquisition time for
the peak plotting. One exception is a study where an ion trap
was sufﬁcient to distinguish between the monomeric and
dimeric form of a metal-protein complex [58]. Modern bench-
top TOF-MS instruments enable the resolution of proteins
up to about 10–20 kDa, whereas high-resolution TOF-MS in-
struments and orbitrap instruments can resolve proteins up
to about 30 kDa [59, 60].
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Table 1. Examples of CE/MS methods and applications for the analysis of small pharmaceutical substances and peptides in the years
2010 and 2011
Analyte Coating BGE SL MS Application Citation
Imatinib (cancer
drug)
M7C4I NH4Ac 30 mM ACN/H2O (50/50 v/v)+10
mM HAc
TOF Quantitative analysis in
human serum
[83]
Tricyclic
antidepressants
M7C4I 30 mM NH4Ac at pH 3 ACN/H2O (50/50 v/v)+10
mM HAc
TOF Drug quantiﬁcation in
human plasma,
pharmaceutical
formulations
[82]
Bioactive peptides - 1 M HAc CE-IT-MS: IPA/H2O (60/40
v/v) + 0.05% v/v FA
CE-TOF-MS: same with
diluted reference
substances
Ion trap, TOF Peptide identiﬁcation in
enzymatic bovine milk
digest
[77]
Substance P, its
aminoacids
- 25 mM HAc+25 mM FA
pH 2.5–5.0
50% MeOH + 0.1% FA Ion trap Peptide hydrolyzation
characterization in cell
culture
[65]
Rosiglitazone
metformin
- 50 mM FA pH 2.8 MeOH/H2O (50/50 v/v) +
0.5% v/v FA
QTOF Detection in human serum [81]
Tetracosactide - 0.5 M FA H2O/IPA (50/50 v/v) QTOF Impurity detection in drug [79]
D-Carnitine - 0.2% Succ-y-CD in 0.5
NH4FA
IPA/H2O (50/50 v/v) +
0.1% v/v FA
Ion trap Chiral analysis of
pharmaceutical
formulation
[129]
3 Amino acids, peptides, and
small molecules
In the analytical ﬁeld of small pharmaceutical molecules, the
most often employed technique is HPLC, due to its robust-
ness, reproducibility, and wide experience of analysts with
this technique. However in the recent years, CE applications
were implemented as a complementary or orthogonal tech-
nique due to the different separation principles and the pos-
sibility to solve complex analytical problems, which are for
example reviewed by Suntornsuk in 2010 [61]. As can be seen
in the review, most CE methods employ optical detectors like
UV and DAD; however, the detection by ESI-MS is slowly
rising. Examples for this development are shown in Table 1
for 2010 and 2011.
A large part of pharmaceutical substances contain nitro-
gen in form of an amine group (e.g. amino acids, peptides,
alkaloids, etc.). These analytes are mostly separated as cations
in an acidic BGE based on formic or acetic acid, possibly
buffered with ammonium as counter ion. An extensive sum-
mary of BGEs for CE/MS is presented by Pantuckova et al.
2009 [62].
Amino acids can be directly analyzed by CE/MS [63, 64]
using acidic BGEs,mainly based on formic acid. Themajority
of the published applications deal with metabolism studies
or clinical applications [65–69] or the analysis of amino acids
in food [70].
CE/MS is often applied to the analysis of peptides [71],
however,most applications can be found in the context of bio-
logical,metabolism, or clinical issues. As this application area
is rather large and so far only ofminor interest in the pharma-
ceutical context, we refer to existing reviews [72–76]. Several
recent studies deal with the identiﬁcation of peptides in com-
plex biological samples, as bovine milk protein hydrolysate
[77] and enzymatically digested human cell cultures [65]. In
both cases, bare fused-silica capillaries with an acidic BGE
were hyphenated via ESI-interface to an Ion trap. Stanova
et al. [78] analyzed the therapeutic peptides anserine,
carnosine, and buserelin in human urine. Preparative ITP
was used as sample preparation method increasing the
CE/MS sensitivity (high ppb range) by factors higher
than 25.
CE/MS is well suited for impurity proﬁling of drugs, as
recently demonstrated by our group for the peptidic drug
tetracosactide [79]. Figure 1 shows the comparison of CE/MS
and LC/MS for the characterization of impurities of this 24
amino acids containing peptide. CE/MS turned out to be
better suited than LC/MS for the characterization of peptide
fragments (incomplete synthesis). However, LC/MS showed
a better separation of peptides containing protecting groups,
as these modiﬁcations increase substantially the hydropho-
bicity of the peptides. This example demonstrates the of-
ten observed complementary characteristic of CE/MS and
LC/MS for the analysis of complex peptide mixtures [48, 80].
CE/MS is useful for the characterization of pharmaceu-
tically relevant small molecules. Bare fused-silica capillaries
and a BGE of formic acid at pH 2.8 were used for the analysis
of the diabetes drugs rosiglitazone and metformin in human
blood serum [81]. The resulting method reached an LOD for
rosiglitazone of 4.4 ng/mL and 2.1 ng/mL for metformin,
sufﬁcient for monitoring therapeutically relevant serum con-
centrations.
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Figure 1. TCS sample analysis by RP-HPLC-MS (left) and CE-MS (right): BPC, BPE and ion traces of selected peptides smaller than TCS
(fragments 1–15 TCS, 1–14 TCS, 1–13 TCS, 1–12 TCS, 1–11 TCS, 1–10 TCS, 1–9 TCS, and 1–8 TCS). EICs and EIEs were created by extraction
of the masses of the three main isotopes of the most abundant charge state of the respective peptide (listed in the ﬁgure). The extraction
width was adapted in order to exclude contaminants or isotopes of other ions showing the same nominal mass. The letters indicate the
missing amino acid from one peptide to the following starting with the peptide SYSMEHFRWGKPVGK. The TCS itself is the peak being
out of range, the asterisk indicates the 16D-Lys-TCS diastereomer, the arrow indicates TCS sulfoxide, the number sign indicates TCS+tBu
(not separated from TCS by CE/MS), the plus indicates TCS+tBoc. X denotes peaks arising from background substances or isotopes of
comigrating peptides lying within the speciﬁed extraction width. Modiﬁed from Taichrib et al. 2011 [79]
In some cases, the application of a capillary coating is
also an advantage for the analysis of small pharmaceuti-
cal substances, in order to decrease peak tailing and peak
asymmetries. Elhamili et al. [82, 83] investigated the use of
-iodo-alkyl ammonium salt (M7C4I) coating for the analytic
of tricyclic antidepressants and the anticancer drug imatinib
in human plasma. In both applications, a BGE containing
ammonium acetate and a sheath liquid of 50% ACN with
C© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
Manuscripts
 
19 
Electrophoresis 2012, 33, 1517–1530 CE and CEC 1521
10 mM HAc was used, leading to high separation efﬁciencies
andmigration time repeatabilities. A sample preparation step
using a strong cationic SPE (SCX-SPE) for the extraction of
small basic analytes with restricted access for proteins, en-
ables the analysis, quantiﬁcation, and clinical monitoring of
tricyclic antidepressants and imatinib within blood serum or
pharmaceutical formulations.
The separation of enantiomeric analytes is a major appli-
cation of CE in the pharmaceutical area [12,84], especially for
the determination of enantiomeric purity. However, CE/MS
is not often applied in this ﬁeld as (i) the applied enantioselec-
tors (cyclodextrins) yield ionization suppression and (ii) the
analytes are usually well known. We refer for this subject to a
recent review about CE/MS for the analysis of chiral analytes
[85]. By the way, charged cyclodextrins can be characterized
by CE/MS [86].
4 Intact proteins
4.1 Methods for intact protein analysis
The methods developed for intact protein analysis were
further reﬁned in the last few years and several applica-
tions which are of potential interest for the analysis of
(bio)pharamaceuticals have been developed and investigated.
Based on previous summaries of intact protein analysis by
CE/MS [22,23,87], a short overview of analytes, BGE, sheath
liquid, and application with respect to intact protein analysis
by CE/MS is given in Table 2. Important aspects are dis-
cussed in the frame of previous publications in the following
sections.
4.1.1 BGE
The same BGEs used in CE/MS for peptides and small drugs
can in principle also be used for the analysis of intact proteins.
Although ammonium formate is used in several studies, the
ammonium ionmight result in an additional heterogeneity of
the charge distribution in the ESI, which might diminish the
overall signal intensity of the protein. Thus, acetic or formic
acid are mainly used as BGE for intact protein analysis by
CE/MS. Acetic acid seems to be advantageous when larger
proteins or glycoproteins are analyzed. Formic acid provides
a lower pH, which might be beneﬁcial for acidic proteins
and in order to obtain a charge distribution at higher charge
states, i.e. at lower m/z values.
4.1.2 Prevention of protein–capillary interaction
A major problem of capillary electrophoresis for the anal-
ysis of proteins/peptides is the potential adhesion of these
substances to the fused-silica capillary wall [28], since it inﬂu-
ences the number of theoretical plates, peak width, and thus
the resolution. It can even lead to complete loss of analyte
signal at the detector. Additionally, protein adhesion from
previous runs inﬂuences the repeatability of the EOF and the
migration times. The process of adhesion from protein to
the fused-silica wall is governed mainly by charged residues
in the protein, which ﬁrst contact to the opposite charged
capillary wall. The adhesion processes are governed mainly
by electrostatic or hydrophobic interactions. For an extensive
discussion of the process of protein adhesion, see a review
from Stutz [28].
The main strategies to prevent protein adhesion have
primarily focused on the prevention of ﬁrst contact between
the protein and the fused-silica surface of the capillary, either
by a strong acidic or basic BGE, coating of the capillary wall
or by the use of BGE additives. The latter is generally not
recommended when ESI-MS is used as detector for CE.
4.2 Bare fused-silica capillary
In some papers, bare fused-silica capillaries were used for
the analysis of proteins. In order to minimize the protein
adhesion,mostly strong acidic or basic BGEs are required. For
example Staub et al. [88] used 75mMammonium formate at a
pH of 9.5 for the separation of Oxyglobin R© fromhemoglobin,
with a migration time RSD smaller than 2% (N = 10).
The use of strong acidic or basic BGEs, however, often
results in protein denaturation and/or protein degradation.
Borges-Alvarez [58] compared the usability of a 1 M HAc
buffer at pH 2.3 with a NH4Ac buffer at pH 7.3 for the analyt-
ics of bovine Cu, Zn-superoxide dismutase. In its native form,
the dismutase occurs as a Cu2Zn2-dimer, which resulted in
a single sharp peak when using 10 mM NH4Ac (pH 7.3).
The use of the acidic HAc, however, resulted in two distinct
peaks with the main peak close to the mass of the protein
monomer, showing that the native enzyme was denaturated
by the acidic conditions.
4.3 Use of organic modiﬁers
Organic modiﬁers can be added to the BGE altering the hy-
drophobic properties of the protein for further decrease of
protein adsorption. This principle was used in a study by
Staub et al. [89] for the separation of human growth hormone
(hGH) from the recombinant form (rhGH). The previously
used basic BGEs, leading to protein degradation and some
protein adsorption (and thus instable migration times), were
replaced by an acidic BGE. In order to prevent adsorption, use
of organic solvents (ACN, MeOH, and EtOH) in the range of
5–80% v/v were investigated via CE-UV. The best results re-
garding adsorption reduction andpeak stabilitywere achieved
using a BGE consisting of 75 mM ammonium formate with
20% ACN. After optimization of the ESI source parameters
via design of experiments, the developed method could be
deployed in CE/TOFMS, using IPA/H2O/FA (50:50:0.05
v/v/v) as sheath liquid. With the developed method, the dis-
tinction of hGH from rhGH was possible via electrophoretic
mobility differences and differences in the isoform
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Table 2. CE/MS methods and applications for the analysis of intact proteins in the years 2010 and 2011
Analyte Coating BGE SL MS Application Citation
-Chymotrypsinogen
A, ribonuclease A,
lysozyme,
cytochrome c
PB-DS-PB 50 mM HAc pH 3 IPA/H2O (75/20 v/v)
+ 0.1% v/v HAc
TOF Method development [94]
RhGH PB-PVS 75 mM NH4FA pH
8.5
ACN/H2O (75/25
v/v) + 5% v/v FA
TOF Characterization of
biopharmaceutical
formulations
[93]
Oxytocin PB-DS-PB 525 mM HAc pH 3 IPA/H2O (75/25 v/v)
+ 0.1% v/v HAc
rhIFN- PB-DS-PB 50 mM HAc pH 3 IPA/H2O (75/25 v/v)
+ 0.5% v/v HAc
Drug-lysozyme
conjugates
PEI 100 mM HAc pH 3
+ 5% v/v IPA
Sheathless porous
sprayer
TOF Characterization of drug
conjugate
[96]
Insulin, ribonuclease
A, carbonic
anhydrase,
lysozyme
PEI 100 mM HAC pH 3
+ 5% v/v IPA
Sheathless porous
sprayer
TOF Method development [50]
Intact glycosylated
AGP
DMA-EPyM 1 M HAc IPA/H2O (50/50 v/v)
+ 1% v/v HAc
QTOF Glycoprotein characterization
in human serum,
enrichment via antibody
column
[97]
Deglycosylated
protein
LN 1 M HAc IPA/H2O (50/50 v/v)
+ 1% v/v HAc
rhGH - 75 mM NH4FA pH
2.5 + 20% ACN
IPA/H2O (50/50 v/v)
+ 0.05% v/v FA
TOF Identiﬁcation of rhGH in
lyophilized powder derived
from Doping Analysis Lab
[89]
Hemoglobin-based
oxygen carriers
(HBCO)
- 75 mM NH4FA IPA/H2O (50/50
v/v) + 3% v/v FA
TOF Distinction of human Hb and
oxyglobin (polymerized
bovine Hb) in human
plasma
[88]
Recombinant human
insulin
- 75 mM NH4FA pH
9.0 + 10% ACN
IPA/H2O (50/50
v/v) + 1% v/v FA
TOF Quantiﬁcation, proﬁling in
pharmaceutical
formulation
[130]
Bovine CU, Zn
superoxide
bismutase
- 1 M HAc (10 mM
NH4Ac pH 7.3
also tested)
IPA/H2O (60/40 v/v)
+ 0.5% v/v FA
Ion trap Characterization of
metal-protein complexes
[58]
AHL-lactonase Dynamic polybrene 10 mM NH4Ac +
0.1% polybrene
pH 6.9
Sheathless porous
sprayer
QTOF Metal stoichiometry of
protein-metal complexes
[109]
Growth hormone - 75 mM NH4FA pH
2.5 + 20% ACN
IPA/H2O (50/50
v/v) + 0.05% FA
TOF Method development [90]
Hemoglobin 75 mM NH4FA pH
9.0
IPA/H2O (50/50
v/v) + 3% v/v FA
Insulin 75 mM NH4FA pH
9.0 + 10% ACN
IPA/H2O (50/50
v/v) + 1% v/v FA
rhGH - 40 mM NH4HCO3
pH 8.5
IPA/H2O (1:1 v/v)
+ 0.2% v/v FA
QTOF Biopharmaceutical
formulations
[59]
EPO LN 1M HAc IPA/H2O (1:1 v/v)
+ 1% v/v HAc
distribution: hGH contains a 20 kDa and a 22 kDa isoform,
while rhGH only contains the 22 kDa isoform. In a sub-
sequent study, the effects of reversible and irreversible ad-
sorption were studied on the three model proteins growth
hormone (GH), hemoglobin (Hb), and insulin (INS) [90]. As
estimates for reversible adsorption, the variance of the mi-
gration times after successive analyte injections was used,
while peak area recoveries and EOF conservation were used
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to estimate the irreversible adsorption. The results showed
that the addition of 10% to 20% ACN improved the peak area
recoveries of insulin and growth hormone. However in case
of hemoglobin, the peak area recovery decreased from 100%
to 82%, while the variance of the migration time strongly
increased from 1.7% to 19.7%, showing that both reversible
and irreversible adsorption occurred by addition of ACN. It
can thus be concluded that the addition of organic modiﬁers
may be beneﬁcial for the separation, but has in some cases
deteriorating effects on the peak area recovery and migration
time variance. For this reason, the addition is to be checked
individually for each protein.
4.4 Coatings
An often used strategy to prevent protein wall adsorption is
the use of capillary coatings. In the last several years, a wide
variety of different coatings have been developed for the use
in CE-UV [24,29,30,32,91,92]. Charged coating can suppress
electrostatic interaction by repulsion of the protein from the
identically charged capillary wall. In case of neutral coatings,
the access to the silanol surface is minimized. Using charged
coatings, the direction and magnitude of the EOF can be cho-
sen according to the analytical problem in order to increase
the peak resolution, or to speed up the analysis if sufﬁcient
resolution is already achieved. Despite longitudinal diffusion,
which is small in liquids, the resolution is improved if the an-
alytesmigrate as slow as possible, which can be accomplished
by using an EOF working in the opposite direction than the
migration direction of the analytes. The magnitude of the
EOF has then been chosen (e.g. pH of the BGE) in such a
way that the analytes still reach the detector. Another aspect of
capillary coating is the deployment onto the capillary wall. In
case of dynamic coatings, the coating agent is contained in the
BGE that continuously regenerates the coating surface. Static
coatings are applied via rinsing with coating agent prior to the
analysis. Frequent recoating between runs is often required
to guarantee reproducibility.
In CE/MS, only a small subset of the developed strate-
gies for CE/UV can be used, since some coating agents are
detrimental for the MS or the ionization process [25]. For
example, dynamic coatings are seldom used in CE/MS since
the coating agent in the BGE may suppress analyte signal.
The choice of coating type is also limited, since at least a
low BGE ﬂow toward the ESI source is preferred to prevent
sheath liquid from entering the capillary, otherwise current
instabilities would impair the robustness of the method. The
use and limitations of different coatings and CE modes for
CE/MS has been recently discussed [25]. The following im-
portant contributions in this ﬁeld from the last 2 years are
presented and discussed.
Haselberg et al. investigated the use of a polybrene-based
coating for the use in CE/MS [93, 94]. A bilayer coating con-
sisting of polybrene and poly(vinyl sulfonic acid) (PVS) has
already been used by Catai et al. in 2007 [95], which is only
applicable for acidic proteins, since positively charge pro-
teins bind to the negatively charged PVS. In order to cir-
cumvent this problem for basic proteins, a triple layer of
polybrene–dextran sulfate (DS)–polybrene has been inves-
tigated on the proteins -chymotrypsinogen A, ribonucle-
ase A, lysozyme, and cytochrome c. The coating can simply
be applied by subsequent rinsing of the capillary with PB
solution/DS solution/PB solution with washing steps with
deionized water in between. A BGE of 50 mM HAc at pH 3
and a sheath liquid consisting of IPA/H2O/HAc (75/25/0.1
v/v/v) were applied. Measurements with BGE and a control
experiment containing coating agents showed that the coat-
ing does not lead to any background signals in the mass
spectra. Addition of polybrene to the BGE showed that low
concentrations of polybrene results in no signiﬁcant ion sup-
pression behavior for the model proteins ribonuclease A and
lysozyme.
Based on this work, the usefulness of polybrene mul-
tilayer coatings for the analysis of biopharmaceuticals was
further investigated [93]. In order to test the capabilities of
the bilayer PB-PVS coating for acidic proteins, heat-exposed
rhGH was chosen as model protein. For the triple layer PB-
DS-PB basic analytes, i.e. the nonapeptide oxytocin and its
degradation products as well as the glycoprotein recombi-
nant human interferon--1a (rhIFN-) were chosen. For ideal
separation and ionization of each model protein, different
BGEs and sheath liquidswere applied. The resultingmethods
allow the separation of analytes with modiﬁcations leading to
charge differences from the original protein/peptide.
Another positively charged coating applied by Haselberg
et al. [50, 96] was polyethylenimine (PEI). Since a sheathless
interface (porous sprayer) was employed, an EOF from the
inlet to the ion source stabilizes the ESI spray, which was
achieved by the PEI coating in conjunction with a BGE con-
sisting 100 mM HAc + 5% v/v IPA.
For the analysis of the intact human alpha-1-acid glyco-
protein (AGP), Ongay and Neusu¨ß [97] used the positively
charged acrylamide-pyrrolidine methacrylate coating (DMA-
EPyM), which was introduced by Gonza´lez et al. [98]. AGP
presents a challenge due to its high heterogeneity based on
ﬁve glycosylation sites and different amino acid sequences.
The CE method used reversed polarity with a strong EOF
toward the detector, which allowed the separation of the
isoforms into an overlapping pattern of differently charged
(different number of sialic acids) isoforms. In case of the
deglycsosylated AGP, the DMA-EPyM coating could not be
used, since the high-positive charge of deglycosylated AGP
would cause migration toward the inlet vial overcoming the
moderate anodal EOF. Instead of a cationic coating, a com-
mercially available soluble polyacrylamide precoating was
used. This neutral coating exhibits almost no EOF at low
pH values. A good resolution was obtained through the re-
sulting slow migration of AGP, leading to a separation of
differences of the AGP backbone due to expression variants.
The same soluble polyacrylamide coating was also used in
the characterization of erythropoietin (EPO) by Taichrib et
al. [59], where an excellent separation of EPO glycoforms
is shown. Separation is not only obtained due to charge
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differences (sialic acids) but also due to size of the glycans
(antennarity).
4.5 Applications of intact protein analysis
A major application of intact protein analysis with CE/MS is
the proﬁling and characterization of protein isoforms, which
reveal information about charge differences, amino acid se-
quence differences, protein degradation, glycosylationhetero-
geneity, and other protein modiﬁcations. These differences
are especially important in the biopharmaceutical ﬁeld, since
undetected protein forms or conformations are potentially
harmful for patients and thus have to be monitored in qual-
ity control. The use for proﬁling has been demonstrated in
various papers with the model protein rhGH. Staub et al.
[89] showed the possibility to distinguish endogenous hGH
from recombinant hGH. Catai et al. used a bilayer-coated
capillary and ion trap MS detection to analyze rhGH [99].
They separated several forms of rhGH, postulating deamida-
tion. Taichrib et al. were able to prove this hypothesis due
to isotopic resolution of the 22 kDa protein by the benchtop
TOF-MS [59]. In all cases, baseline resolution of rhGH from
its mono and doubly deamidated forms is possible demon-
strating the high power of CE/MS for this type of application.
Haselberg et al. used rhGHafter heat exposure and prolonged
storage showing the possibility to distinguish further protein
modiﬁcations leading to charge differences [93].
4.6 Glycosylation analysis based on intact proteins
Glycosylation analysis is of great importance in modern bio-
pharmaceutical approaches. CE/MS has been shown to be
very useful for the analysis of the glycosylation pattern of
intact proteins [37, 93, 97, 100–102]. It can be used to opti-
mize the biotechnological process, to distinguish suppliers,
for quality control or for the proof of similarity for follow-
on biologics. One of the best characterized glycoproteins and
important drug erythropoietin is analyzed routinely by CE.
A CE/MS method originally developed by Neusu¨ß, Demel-
bauer, and Pelzing [103] has been improved and well estab-
lished in the last years [59, 101]. It can be applied to charac-
terize EPO samples with respect to the glycosylation pattern,
easily differentiating EPO alpha and EPO beta [104]. Further-
more, the validated method [105] is able to distinguish many
pharmaceutical products and preproduction batches of EPO
based on the glycosylation pattern determined by CE/MS
and subsequent chemometric approaches applying principal
component analysis or cluster analysis [106].
Haselberg et al. used a triple layer coating consisting of
polybrene-cyclo dextene-polybrene for the characterization of
recombinant human interferon ß-1 [93]. The method enables
partial resolution of glycoforms, leading to a distinct pattern
that can be used for glycoform proﬁling.
The analysis of human alpha-acid glycoprotein (AGP)
was described by Ongay et al., studying the intact glycosy-
lated protein, the deglycosylated protein, and the released
glycans by CE/MS [97]. AGP exhibits a high degree of hetero-
geneity in the glycan structure due to its ﬁve N-glycosylation
sites as well as variability of the amino acid backbone leading
together with some amino acids variants to about 150 AGP
isoforms detected by CE/MS. However, unequivocal carbo-
hydrate structures can only be assigned in conjunction with
the analysis of the released glycan. The analysis of the intact
protein showed again, that the separation is primarily based
on different charges with baseline separation of isoforms dif-
fering by one charge (here: sialic acid or amino acid change).
Based on differences in the glycosylation pattern, healthy and
bladder cancer diseased patients could be distinguished [107].
4.7 Intact proteins in serum
A major obstacle in CE/MS is the small capillary volume
which calls for high analyte concentrations in the sample.
For this reason, CE/MS is mainly applicable for the char-
acterization and quantiﬁcation of proteins within pharma-
ceutical formulations where the protein constitutes a large
fraction within the drug and adequate sample amounts can
be used. However, high analyte concentrations of biological
samples can also be achieved via protein enrichment. For
this purpose, speciﬁc antibody columns can be used to tar-
get the analyte itself, which was used for example to enrich
the glycoprotein AGP within human blood plasma with anti-
AGP column, where the AGP was retained on the column
while matrix and residual proteins were removed [108]. This
procedure, however, relies on the availability of an antibody
column for the speciﬁc analyte protein, which is time and
cost consuming to produce. As an alternative, immunodeple-
tion kits for the appropriate sample type can be used which
remove the most abundant proteins that interfere with the
analysis. This procedure has been used for example for the
analysis of hemoglobin-based oxygen carriers like Oxyglobin
(a derivative of bovine hemoglobin) in human serum plasma
from doping controls by CE/MS [88].
4.8 Protein-drug conjugates
CE/MSwas also applied for the characterization of lysozyme–
drug conjugates which are used in advanced drug target-
ing for example in cancer therapy [96]. In such conjugates,
several drug molecules are bound to a carrier protein over
linker molecules. The attachment of the drug and linker to
the carrier protein leads to a distribution of carrier molecule
to drug ratios, which needs to be characterized for batch-
to-batch consistency and synthesis reﬁnement. In this pa-
per, lysozyme modiﬁed by BOC-l-methionine hydroxysuc-
cinimide ester (LZM-BOCmet) was used as carrier protein,
which was coupled to the cis-Pt(ethylenediamine) nitrate–
chloride (Universal Linkage System; ULSTM). For the drug-
conjugate preparations, the platinum-based linker was then
coordinated to the kinase inhibitors LY364947, erlotinib, and
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Figure 2. Analysis of an erlotinib-ULS-BOCmet-LZM preparation (drug-conjugate) with CE-TOF-MS, showing BPE (A), mass spectra (B),
and EIEs (C). The peaks correspond to (1) BOCmet2-LZM; (2) BOCmet1-LZM; (3) LZM; (4) (erlotinib-ULS)1-BOCmet1-LZM; (4) (erlotinib-
ULS)1-BOCmet2-LZM; (4) (erlotinib-ULS)2-BOCmet2-LZM: Reprinted with permission from [96].
Y27632. Figure 2 shows the BPE, mass spectra, and EIEs of
an erlotinib-ULS-BOCmet-LZM preparation. Due to charge
differences induced by the BOC-l-methionine attachment to
lysine residue in the protein, the separation of LZM carry-
ing different number of BOCmet and erlotinib residua into
several peaks is possible with CE/MS.
4.9 Metal-protein complexes
CE/MS of intact proteins can also give insights into the sto-
ichiometry of metal-protein complexes. Borges-Alvarez et al.
showed that the pH of the BGE is a crucial factor to prevent
metal depletion and dissociation of the complexes [58]. The
application of 10 mM NH4Ac at pH 7.3 allowed the detec-
tion and differentiation between Cu,Zn-superoxide dismu-
tase (SOD) in its monomeric (Cu,Zn-SOD) and dimeric form
(Cu2,Zn2-SOD). Moini reported that metal displacement in
proteins can also be studied by CE/MS [109]. As proof of con-
cept, the displacement of Co(II) by Cd(II) within the protein
N-acyl-L-homoserine-lactonase (AHL) in itsmonomeric form
has been used.
5 Carbohydrates
Next to intact protein and glycopeptide characterization as de-
scribed before, the detailed characterization of glycosylation
based on the released carbohydrates is mandatory since the
high variability of glycan structures leads to complexmixtures
and several combinations with a certain mass [36, 110].
N-glycans, (N-glycosidic bonded via asparagines) can be
easily cleaved from the protein backbone using a glycosidase
(e.g. PNGase F). The analyses of N-glycans based on CZE-
and CGE-LIF [111–113] are promising and powerful tools in
the pharmaceutical industry. The methods present efﬁcient
separation of glycan isoforms, short analysis time combined
with high sensitivity detection. However, the conﬁrmation
and characterization of glycans is time consuming, as CE is
not scalable toward a (semi)preparative technique. Therefore,
the combination of CE or CE-LIF and mass spectrometry is
a fast and helpful tool to identify unknown glycan species
[36,114–116]. The developments inCE/MS for glycan analysis
in the years from 2006 to 2011 are summarized in Table 3
and discussed in detail in the following sections.
5.1 Nonderivatized glycans
Generally, the electrophoretic separation and the ESI-
ionization process require charged glycans. A common
constituent of complex glycans are sialic acids. Due to a
negatively charged residue, sialylated glycans can be ana-
lyzed after release by CE/MS without any further treatment
[37, 117]. One possibility is the analysis in bare fused-silica
capillaries with basic background electrolytes. The resulting
strong EOF transports the glycans against their mobility
from the inlet to the mass detector with high resolving
power. Basic BGE systems based on 0.9 M ammonia, 0.1 M
6-aminocaproic acid, and high percentages of methanol (see
Table 3) were presented for the characterization of glycans
from erythropoietin, fetuin, and AGP [37,97]. A sheath liquid
containing 50% 2-propanol without any further additives
was applied. This fast and simple method provides detailed
information about type and composition of the released
glycans.
Similarly, the analysis of phosphorylated or sulfated gly-
cans is expected to be possible, however, to our knowledge,
this has not been shown so far.
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Table 3. CE/MS methods and applications for the analysis of glycans in the last years (2006–2011)
Analyte Coating BGE SL MS Citation
Fetuin, AGP, and rHuEPO
glycans
- 0.1M 6-aminocaproic
acid, 0.9 M NH4Ac in
70% MeOH
IPA/H2O (50/50 v/v) QTOF [37]
AGP glycans - 0.1 M 6-aminocaproic
acid + 0.9 M NH3 in
40% MeOH
IPA/H2O (50/50 v/v) QTOF [97]
Human plasma N-glycans
2-AA-labeled
- 10 mM HAc /50 mM NH3
+ 50% MeOH
IPA/H2O (50/50 v/v) QTOF [123]
10 mM HAc /50 mM NH3
Fmoc-labeled glycans - 50 mM NH4Ac MeOH/H2O (50/50 v/v) + 0.1% v/v FA Ion trap [124]
rMAb glycans
APTS-labeled
PVA 40 mM 6-aminocaproic
acid (pH 4.5, HAc)
IPA/H2O (50/50 v/v) + 0.2% v/v NH3 QTOF [119, 126]
Transferin and fetuin
glycans APTS labeled
PVA IPA/H2O (20/80 v/v) + 15
mM HAc (pH 4.75)
IPA/H2O (20/80 v/v) + 15 mM HAc QTOF [120]
Human milk
oligosaccharides APTS
labeled
- 0.3% FA (pH 2.4) IPA/H2O (50/50 v/v) Ion trap [125]
5.2 Derivatized glycans
Glycans without any ionic group need derivatization prior to
CE/MS analysis. Labeling protocols have been recently re-
viewed [118]. Preferably, well-studied ionic labeling reagents
of common CGE-LIF methods are also applied for CE/MS.
Widely used derivatization reagents for CGE-LIF that also
have been used by CE/MS include the negatively charged
9-aminopyrene-1,3,6-trisulfonic acid (APTS) [119, 120], 8-
Aminonaphthalene-1,3,6-trisulfonic acid (ANTS) [121, 122],
or 2-aminobenzoic acid (2-AA) [123]. In recent years, CE/MS
method development for N-glycans (in the biomedical con-
text) was focused on APTS-labeled glycans. The reason is the
widespread use of CGE-LIF systems often appliedwith a com-
mercially available carbohydrate analysis kit for APTS-labeled
N-glycans and the use of an argon-ion laser as a convenient
light source [36].
Cationic labeling reagents like the commonly used 2-
aminobenzamid (2-AB) in HPLC can also be applied to
CE/MS. However, the negative charge of attached sialic
acids can form neutral or negatively charged glycans, which
should be taken into account during method development.
The potential formation of neutral species may constrain
the applicability of positively charged labels for sialylated
glycans.
5.3 Basic background electrolytes
Derivatized glycans with negatively charged label can be sep-
arated in bare fused-silica capillaries and basic BGE systems
as described for the sialylated glycans. Ruhaak et al. [123]
published a method for 2-AA-labeled glycans in fused-silica
capillaries. A separation electrolyte of 10 mM acetic acid, 50
mM ammonia enables a fast separation at normal polarity
within 5 min. The addition of 50% methanol can enhance
the separation efﬁciency, since, size and shape of N-glycans
get more inﬂuence [123]. Nakano et al. [124] published a sim-
ilar method with 50 mM ammonium acetate and a sheath
liquid consisting of 50% methanol and 0.1% of formic acid.
However, the presented method is based on an alternative
and high-sensitive labeling with 9-ﬂuorenyl chloroformate
(Fmoc-Cl). The Fmoc labeling method is described as more
rapid compared to other labels due to a simple and direct la-
beling procedure. Nevertheless, the presented separation of
fetuin glycans seems not as efﬁcient as shown for unlabeled
fetuin glycans [37].
5.4 Acidic background electrolytes
Methods based on an acidic BGE similar to the advanced CE-
LIF method are aimed for CE/MS analysis of APTS-labeled
glycans [119,125]. Hereby, the negatively charged glycans are
separated according to their mobility from the cathodic inlet
to the anode. Based on a low pH level, the dissociation of
capillary silanol groups is reduced and results in a very low
electroosmotic ﬂow (EOF). Albrecht et al. [125] used uncoated
capillaries for APTS-labeled oligosaccharides in human milk.
A BGE of 0.3% formic acid at pH 2.4 suppresses the EOF and
enables a separation at reversed polarity. The analysis was
performed on an online CE-LIF-MS system in comparison
to a routine CE-LIF approach. The standard CE-LIF method
was modiﬁed for CE-LIF-MS analysis, whereby, for breast
milk oligosaccharides 19 peaks in online CE-LIF-MS and 37
peaks in ofﬂine CE-LIF were detected. Maxwell et al. [53]
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Figure 3. (A) Typical CE-LIF electro-
pherogram of APTS-labeled glycans
from an rMAb. (B) CE-MS base peak
electropherogram (using the modiﬁed
method as stated in the text) of glycans
from the same rMAb. Reprinted with per-
mission [126].
presented a related method for APTS-labeled glycans in bare
fused-silica capillaries. Different BGE compositions of formic
or acetic acid and methanol were tested. The best resolution
for a glucose ladder standard was achieved by 2% formic acid
and 30% methanol. A valuation of this method in respect
of separation efﬁciency is difﬁcult, due to the use of simple
glucose unites.
In slightly acidic BGE systems, a neutral coating is used
to suppress the EOF. Next to the widespread used polyvinyl
alcohol (PVA) coatings, there are several further physically
adsorbed and covalent coatings like soluble polyacrylamide
and permanent polyacrylamide (PAA), which can be used as
neutral EOF suppressing layers as well [25].
Two examples for acidic BGE systems in neutral-coated
PVA capillaries for APTS derivatized glycans were presented.
Gennaro et al. [119, 126] applied a separation electrolyte of
40 mM 6-aminocaproic acid (pH 4.5 adjusted with acetic
acid). The sheath liquid of 50% 2-propanol contains addition-
ally 0.2% ammonia. The CE/MS method was adapted from
an existing CE-LIF method. The study showed well-separated
glycans, similar to the CE-LIF method; for example, the iso-
meric glycans G1 and G1′ were clearly separated. Figure 3
presents two electropherograms of isomer separated APTS-
labeled glycans from an rMAb for CE-LIF and CE/MS analy-
sis. Szabo et al. [120] used an acidic electrolyte consisting of
15 mM acetate buffer at pH 4.75, the sheath liquid was mixed
of 80% BGE and 20% 2-propanol. The method was applied
on a very short PVA capillary (30 cm) to optimize several
important sample preparation steps for CE-LIF and CE/MS
analysis with respect to reaction time and consumption of
APTS reagent. The separation efﬁciency seems to be limited
compared to the separation of unlabeled fetuin glycans [37],
however, an accurate comparison is difﬁcult.
5.6 Concluding remarks regarding glycan analysis
The analysis of complex glycan mixtures by CE/MS in the
pharmaceutical area is still challenging, especially, in terms
of high separation efﬁciency and reproducibility. For glycan
analysis, in the (bio)pharmaceutical ﬁeld, the separation of
structural isomers is of high importance. The use of com-
parable glycan isomer standards, like G1 and G1′ would be
reasonable in future reports in order to allow the comparison
of separation efﬁciencies.
At this point, the acidic method based on 6-aminocaproic
acid in PVA-coated capillaries [119] seems to be best suited to
separate and identify unknown glycans from the standardCE-
LIF approach.Unfortunately, themethod seems to be difﬁcult
to reproduce and not robust in this form (unpublished mea-
surements). Therefore, further developments are necessary
for routine glycan analysis by CE/MS. Alternatively, a basic
BGE system would be applicable for APTS-labeled glycans,
with promising results in terms of structural isomer separa-
tion.However, the comparability with common acidic CE-LIF
methods is complicated by diverse migration patterns. Fur-
thermore, sensitivity of CE/MSneeds to be increased in order
to detect minor glycan species, since (i) injection amount is
low in CE and (ii) CE/MS reveals a lower sensitivity compared
to high-sensitive CE-LIF systems.
6 Validation/quantitation
Method validation is of major importance in the pharma-
ceutical context with respect to both reliability and quanti-
tation. However, detailed validation is rarely performed as
most methods in CE/MS are in an early stage with respect to
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routine application and CE/MS is mainly used in research.
In general, CE/MS can be used similarly to LC/MS for pre-
cise and reliable quantitation [127]. Both CE/MS and LC/MS
depend mainly on properties of the electrospray ionization
leading to precision in the order of 10%, especially since iso-
topically labeled internal standards are often not available.
Precision in migration time is often low as it depends to a
large extent on surface processes (The determination of the
EOF and the stability of the coating are of major importance–
cp. above). However, using mobilities rather than migration
times, the precision is often better than 1% RSD. Dynamic
range of CE/MS can be as high as 3–4 orders of magnitude
being sufﬁcient for almost any pharmaceutical application
[127]. Typical sensitivity achievable in CE/MS is in the upper
attomol- to low femtomol-range, depending on the MS used.
This corresponds to high ppb range for small molecules in-
jecting a few nanoliters. CE/MS can be robust with respect to
several parameters, depending on separation system (BGE,
coating) and the interface. The standard sheath-liquid inter-
face with the sprayer on ground is very robust tomany param-
eters, like position of the capillary, sheath liquid composition
(high organic content can cause instabilities), ﬂow rate, etc.
[128]. A validation of a method for the analysis of intact pro-
teins by CE/MS has been recently performed [105].
7 Concluding remarks
A major limitation of CE (and thus CE/MS) is the lack of con-
centration sensitivity due to small injection volumes. How-
ever, this is not the limiting factor in the context of drug
substance or drug formulation analysis. Biological samples
are approachable after sample preparation, whereas impurity
proﬁling can be performed straightforward as CE separation
is tolerant to overloading. Thus, CE/MS is expected to be
much more applied in the pharmaceutical area in the future.
This is especially the case where CE/MS shows a beneﬁcial
selectivity compared to LC/MS. Various applications of small
molecule and peptide analysis show the potential of CE/MS
andwill certainly lead to amorewidespread application of this
powerful technique. Intact protein analysis and glycan char-
acterization CE/MS will be a major application of CE/MS in
the (bio)pharmaceutical ﬁeld.
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Abstract The glycosylation of proteins is of particular in-
terest in biopharmaceutical applications. The detailed char-
acterization of glycosylation based on the released carbohy-
drates is mandatory since the protein stability, folding, and
efficacy are strongly dependent on the structural diversity
inherent in the glycan moieties of a glycoprotein. For glycan
pattern analysis, capillary electrophoresis with laser-induced
fluorescence using 8-aminopyrene-1,3,6-trisulfonic acid
(APTS)-labeled glycans is used frequently. In this paper, a
robust capillary electrophoresis–mass spectroscopy method
both for the analysis of APTS-labeled glycans and unlabeled
charged glycans is presented. The background electrolyte
consists of 0.7 M ammonia and 0.1 M ε-aminocaproic acid
in water/methanol 30:70 (v/v). High separation efficiency
including separation of structural isomers was obtained.
The method was validated in terms of reproducibility and
linearity. Submicromolar sensitivity is achieved with linear-
ity up to 24 μM. The ability to analyze APTS-labeled, as
well as unlabeled, charged glycans enables the determination
of labeling and ionization efficiency: APTS-labeled glycans
show a factor of three better ionization efficiency compared to
non-labeled native glycans. The presented method is applied
to the analysis of pharmaceutical products. Furthermore, the
system can be applied to the analysis of 2-ANSA-labeled
glycans, though separation efficiency is limited.
Keywords APTS . 2-ANSA . CE-MS . Glycan .
Glycosylation
Abbreviations
AGP α1-Acid glycoprotein
2-ANSA 2-Aminonaphthylsulfonic acid
APTS 8-Aminopyrene-1,3,6-trisulfonic acid
EACA 8-Aminocaproic acid
CFG Consortium for Functional Glycomics
CSE Capillary sieving electrophoresis
SL Sheath liquid
Introduction
The development of protein-based pharmaceutical products
has increased in recent decades, due to their high potential to
selectively treat diseases. Many pharmaceutically relevant
proteins including antibodies are glycosylated. The study
of glycosylation can be performed on different principles.
Next to intact protein and glycopeptide characterization, the
detailed characterization of glycosylation based on released
carbohydrates is mandatory since the protein stability, fold-
ing, and efficacy are strongly dependent on specific
glycosylation [1–6]. The analysis of N-glycans based on
capillary electrophoresis with laser-induced fluorescence
(CE-LIF) is widespread and a fast tool in the pharmaceutical
industry [7–9]. In this context, derivatization is mandatory
for glycans with respect to separation (permanent charge)
and detection (fluorescence) [10]. The most abundant deriv-
atization reactions in this field are based on a reductive
amination using the reducing glycan termini; thereof, 8-
aminopyrene-1,3,6-trisulfonic acid (APTS) is one of the
most popular labeling agents [11–13]. Furthermore, com-
mercially available analysis kits promote widespread appli-
cation. CE-LIF for APTS-labeled glycans often uses
pseudogels, which are high-viscosity compounds that
achieve sieving effects (i.e., separation due to size) [7, 14].
These capillary sieving electrophoresis (CSE—term is used
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according to IUPAC nomenclature [15]) methods with LIF
detection provide high resolving power, i.e., separation of
structural isoforms and short analysis time combined with
highly sensitive detection. However, since the direct confir-
mation and characterization of glycans is not possible by LIF
detection, an alternative detection technique is required. The
combination of CE and mass spectrometry is a powerful
tool to identify unknown glycan species [13, 16–20].
However, the common CSE-LIF methods are not com-
patible with mass spectroscopy (MS) detection, since
applied pseudogels and electrolytes as phosphates are
not volatile. Few CE-MS methods using APTS-labeled
glycans have been presented [11, 20–23]. However, the
separation efficiencies are either low or difficult to
compare as different glycans have been analyzed. The
acidic CE-MS system by Gennaro and Salas-Solano and
Liu et al. [11, 22] presents high separation efficiency
(i.e., G1F and G1F′ can be separated, see structure in
Fig. 1) comparable to the here-proposed method. The
presented CE-MS methods use acidic background elec-
trolyte (BGE) systems, e.g., based on formic acid [21,
23] or ε-aminocaproic acid (EACA) [11, 20, 22]. Acidic
CE-MS systems with negligible electroosmotic flow
(EOF) might be sensitive to pressure influences (i.e.,
siphoning effects, nebulizer gas flow, etc.) and bear
the risk of air or SL intake or creation of a moving
ion boundary from outlet to inlet. CE-MS systems cre-
ating an EOF in MS direction as basic BGE systems
can prevent these effects. However, CE-MS methods
using basic BGEs have been developed for the analysis
of native glycans [24–26].
Here, a robust CE-MSmethod based on a basic electrolyte
with cathodic detection for APTS-labeled glycans as well as
charged native glycans was developed and validated. The
basic BGE creates a strong EOF towards the MS, thus,
carries the negatively charged native glycans (bearing sialic
acids, sulfonic acids, or phosphates) as well as APTS-labeled
glycans to the MS, resulting in high resolution power. As
indicator for acceptable separation efficiency, the resolution
of the two isomeric glycans of G1F is chosen, as these
glycans are often abundant in antibodies. G1F-glycans are
asialo-, biantennary complex-type N-glycans with one ga-
lactose attached to either end of the antennae (Fig. 1). Addi-
tionally to APTS-labeled glycans, the 2-ANSA label was
applied on this CE-MS method. As shown for 5-ANSA, this
type of label is applicable to HPLC, CE, and—in contrast to
APTS—also to matrix-assisted laser desorption/ionization
(MALDI) mass spectrometry [27, 28]. However to our
knowledge, no CE-MS method has been presented.
Materials and methods
All solutions were prepared using ultrapure water (18 MΩ
cm at 25 °C, SG Ultra Clear UV from Siemens Water
Technologies, USA). 2-Propanol, methanol (each LC-MS
grade), acetic acid (p.a.), formic acid (p.a.), sodium hydrox-
ide (p.a.), and aqueous ammonia (30 % p.a.) were obtained
from Carl Roth GmbH und Co. KG (Karlsruhe, Germany).
Ammonium acetate (p.a.), ammonium carbonate (p.a.),
EACA, sodium cyanoborohydride (NaCNBH3) in 1.0 M
tetrahydrofuran, and citric acid monohydrate (p.a.) were
obtained from Sigma-Aldrich (Steinheim, Germany). “ES
Tuning mix” solution was obtained from Agilent Technolo-
gies (Waldbronn, Germany). Native glycan standards,
APTS-labeled, and 2-ANSA-labeled IgG glycans were
obtained from Ludger (Abingdon, UK). APTS-labeled gly-
cans of pharmaceutical products were provided by Merck
Serono (Rome, Italy). APTS-labeled glycans from bovine
α1-acid glycoprotein (AGP) were obtained from Solvias
(Basel, Switzerland). APTS-labeled A1F standard was par-
tially labeled as follows: 5 μg of glycan standard was labeled
with 1.5 μL APTS solution (20 mM APTS in 0.6 M citric
acid), 1.5 μL 0.6 M citric acid, and 1.0 μL 1.0 M NaCNBH3
in tetrahydrofuran for 1 h at 37 °C. After incubation, 21 μL
water was added resulting in a final concentration of 96 μM.
Fig. 1 Structures of all glycan standards used in this work. The glycan
structures are displayed according to the CFG nomenclature: blue
squares, N-acetylgalactosamine; green circles, mannose; yellow circles,
galactose; red triangles, fucose; violet diamond, N-acetylneuraminic
acid
8278 S.-C. Bunz et al.
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CE
CE experiments were performed in fused silica capillaries of
90, 60, or 43 cm length (Polymicro Technologies, AZ, USA)
at +30 kV (inlet) on a CE 7100 instrument (Agilent,
Waldbronn, Germany). Background electrolytes were based
on ammonia and EACA, ammonium acetate or ammonium
carbonate, each containing a high percentage of methanol as
described in the text. After optimization, the final BGE
contained 0.1 M EACA and 0.7 M ammonia in 30:70
water/methanol with an apparent pH of 10. The capillary
was flushed with methanol, 1 M sodium hydroxide, and
water before the first use or after storage. The sample was
injected hydrodynamically by the application of a pressure of
usually 50 mbar for 12 s. The injection was followed by
dipping the capillary into a water vial in order to prevent
contamination of the BGE. For CZE-MS coupling, a coaxial
sheath–liquid interface was used (Agilent Technologies).
Sheath liquid of 2-propanol/water 1:1 (v/v) is supplied by
syringe pump at a flow rate of 4 μL/min.
MS
MS experiments were performed on a Q-TOF instrument
(microTOFQ, Bruker Daltronik, Bremen, Germany).
Electrospray ionization was used in negative ion mode ap-
plying 4.0 kVon the MS inlet (sprayer on ground). The flow
rate of dry gas (nitrogen) was 4.0 L/min at a temperature of
170 °C. The nebulizer gas pressure was set to 0.2 bar. Spectra
were acquired in a mass range of m/z 300–2,500 at a rate of
1 Hz (summation of 5,000 single spectra). An external cal-
ibration was performed by infusing tuning mix solution at
4 μL/min every morning. As post-processing, the data were
internally calibrated based on observed sodium–EACA clus-
ters. The identification of glycans was based on the accurate
mass of doubly and triply charged glycans (mass deviation
<5 ppm). Data analysis was performed using DataAnalysis
Version 4.0 from Bruker Daltronik (Bremen, Germany). The
identification could be verified by comparison of the isotopic
distribution, i.e., overlaying the simulated mass spectra with
the measuredmass spectra. All glycan structures are displayed
using the simplified Consortium for Functional Glycomics
(CFG) nomenclature: square, N-acetylhexosamine; circle,
hexose; trangle, fucose; diamond, sialic acid.
Results and discussion
Method development
Starting point of the development was a method for the
analysis of native glycans using a BGE of 0.1 M EACA
and 0.9 M ammonia with methanol in a ratio of 30:70 [24].
Since the application of this method to APTS-labeled gly-
cans resulted in broad peaks and reduced separation, an
appropriate method was developed. The BGE contained
ammonia, EACA, and methanol at varying concentration.
The decrease of ammonia concentration in BGE from 0.9 to
0.7 M improves the resolution of the APTS-labeled glycans,
while peaks got sharper and the intensities increase. Further
reduction of ammonia results in longer analysis time, with
hardly any improvement in separation efficiency. In a range
of 50–70 % methanol, a higher percentage of methanol
enhances the peak resolution and intensities, while increas-
ing the analysis time. In the proposed method, a concentra-
tion of 70 % of methanol was chosen in order to separate
isomeric glycans. Lower methanol content can be applied if
shorter analysis time is required. Reduction to 50 % metha-
nol shortens the analysis by a factor of 1.5.
Alternative background electrolytes as 100 and 50 mM
ammonium acetate and 50 mM ammonium carbonate each in
50 % methanol/water (v/v) were tested. However, no accept-
able separation (i.e., low resolving power and broad peaks)
could be achieved. Finally, the separation was performed
using a BGE of 0.7 M ammonia and 0.1 M EACA in 70 %
aqueous methanol in bare fused silica capillaries with an
apparent pH of 10 (measured with water-based calibration
of pH electrode).
The presented method offers the possibility to analyze
APTS-labeled in parallel with charged, unlabeled glycans
as sialylated glycans (negatively charged in alkaline BGE).
Figure 2 shows the base peak electropherogram of α1-acid
glycoprotein glycans (AGP, bovine), which were partially
labeled by APTS. The charged native glycans (22–31 min)
are clearly separated from the APTS-labeled glycans (31–
45 min). The main peaks are biantennary N-glycans of
complex type with different amounts of sialic acids as anno-
tated in Fig. 2 being detected both as labeled and unlabeled
species. The non-labeled biantennary glycan without sialic
acid is uncharged, thus migrates with the EOF and was not
detected by ESI-MS. This example presents nicely the ability
of the new method for parallel separation of charged native
and APTS-labeled glycans.
Separation efficiency
The CSE-LIF methods provide high separation efficiency,
which is important for glycan analysis in the biopharmaceu-
tical sector. Therefore, an important method criterion for CE-
MS is high separation power, e.g., the ability to separate
structural isomeric glycans similar to CSE-LIF. The separa-
tion of the two isoforms of G1F, as abundant structural
isomers in protein-based biopharmaceuticals, was examined
as marker for efficient structural isomer separation. The
isomers were separated due to their different effective size
(charge due to dissociation of APTS is expected to be
CE-MS Analysis of native and APTS-labeled N-glycans 8279
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identical). The 1,3-linked isoform showed shorter migration
time than the 1,6-linked glycan. A resolution of 1.2 was
obtained for G1F of a recombinant fusion protein using the
proposed CE-MS system, though in CSE-LIF a resolution of
1.8 could be achieved using the method of Ruhaak et al. [29]
(data not shown). The differences in CE-MS and CE-LIF
were probably caused by sieving effects of the pseudogel
electrolyte in CSE-LIF as well as different BGE composi-
tions (e.g., pH, solvation of the analytes, viscosity).
The overall separation efficiency is demonstrated for a
complex glycan mixture of a therapeutic antibody. The 15
glycans are baseline separated (compare Fig. 5, depicted lat-
er), including further pairs of structural isomers beside G1F.
Validation
Reproducibility experiments based on APTS-labeled gly-
cans from a recombinant fusion protein were conducted in
12 runs over 5 months. The measurements were analyzed in
terms of variance in migration time, relative peak ratio, and
separation efficiency based on the four main glycan species
G0F, G1F, G1F′, and G2F (see structures Fig. 1). Different
capillaries with same capillary lengths (90 cm) were applied.
The relative standard deviations of migration time, relative
peak ratio (intensity) for the four main glycans (G0F,
G1F/G1F′, and G2F) and the resolution based on the FWHM
of G1F/G1F′ were determined, as listed in Table 1. The three
parameters show an acceptable precision for the characteri-
zation of glycans.
The linearity was determined using APTS-labeled A1F in
a concentration range of 1.5–48 μM. A1F is a mono-
sialylated, core-fucosylated biantennary complex-type N-
glycan (Fig. 1). This naturally charged glycan was chosen
since the actual concentration of APTS-labeled glycan (i.e.,
corrected for labeling efficiency) could be determined using
the approach described in the following paragraph. A
concentration of 48 μMAPTS-labeled A1F in stock solution
was calculated. Based on this stock solution, all calibration
standards were diluted. Instead of a 90-cm capillary length as
used for separation, here, a length of 43 cm is used, since
there is no need of high separation efficiency in this purpose
and analysis time can be reduced. However, a comparison of
peak width and intensity in 43 to 90-cm-long capillaries was
performed to ensure the applicability of 43 cm capillary
length in this context. Furthermore, about the same amount
of analyte was injected (10 nL of sample, injection 6 s
instead of 12 s at 50 mbar) to ease the transfer to standard
separation conditions. Each concentration was analyzed
twice; the calibration plot is displayed in Fig. 3.
The calibration regression factor of 0.9988 was calculated
in a range of 1.5–24 μM. At a level of 48 μM, the calibration
curve is no longer linear, as shown in Fig. 3. A limit of
detection of 0.2 μM (1.9 fmol injected) and a limit of quan-
titation of 0.7 μM (6.7 fmol injected) was calculated based
on signal-to-noise-ratio of 3 and 10, respectively. Thereof, a
total amount of about 1 pmol of glycan arises from the
required sample amount of about 5 μL in CE. The dynamic
range of almost 2 orders of magnitude is appropriate for the
application to glycan identification of biopharmaceutical
products as concentrations are frequently in the nanomolar
to low micromolar range and quantitation is usually not
performed by CE-MS but rather by CE-LIF.
Ionization and labeling efficiency of APTS-labeled glycans
The presented method enabled the determination of labeling
efficiency for APTS-labeled sialylated glycans, since the
unlabeled glycans were detectable in parallel. Also, the dif-
ferent ionization behavior of APTS-labeled to unlabeled
glycans could be determined. Therefore, a native A1F glycan
sample was measured first. Afterwards, the same sample
solution was partially APTS-labeled (at 37 °C for 1 h, see
Fig. 2 Base peak
electropherogram of APTS-
labeled glycans from bovine
AGP separated in fused silica
capillary of 86 cm length
applying the proposed basic
BGE system (0.1 M EACA and
0.7 M ammonia in 30:70 water/
methanol). The main glycans are
annotated: squares, N-
acetylhexosamine; circles,
hexose; triangles, fucose;
diamonds, sialic acid
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“Materials and methods”) to obtain a solution with native
and labeled glycans. The unlabeled amount of A1F in the
labeled sample was quantified based on the first analyzed
native sample. Assuming the rest to be labeled, the ionization
efficiency could be calculated. Figure 4 shows the electro-
pherograms of the analyzed native and labeled A1F sample.
About 4 % of the A1F standard was found to be desialylated
(A1F → A0F) during the labeling process (peak 3). Two
percent desialylated A1F was observed at the peak of A1F
obviously related to a desialylation in the mass spectrometer.
The labeled peak area was calculated by summing up all
labeled peak areas, sialylated and desialylated A1F, assuming
that the error caused by differences in ionization efficiency is
negligible. The native A1F sample and the APTS-labeled
solution of A1F were analyzed twice within some weeks.
Table 2 shows the areas of unlabeled, expected labeled (as-
suming the same response as unlabeled), and detected labeled
peak area related each to the unlabeled native A1F sample.
The ionization of the APTS-labeled glycan (here, A1F) was a
factor of 2.9 enhanced compared to the non-labeled glycan.
The calculated labeling efficiency was about 44 % for the
A1F standard using the described labeling procedure. For
pharmaceutical products, the labeling procedure should be
adjusted dependent on the containing glycans. Highly
sialylated glycan mixtures are usually treated carefully (at
37 °C) to avoid loss of sialic acids [12]. Hence, for provided
pharmaceutical products with sialylated glycans, a labeling
efficiency of around 50 % was determined. For glycan mix-
tures containing no sialic acids, the labeling reaction time could
be expanded and the reaction temperature decreased (60 °C);
thus, a labeling efficiency of 80–90 % was determined.
Application to pharmaceutical products
The method was successfully applied to identify and char-
acterize the APTS-labeled glycans of three different pharma-
ceutical products: a therapeutic antibody, a recombinant
fusion protein, and a cytokine-based product. The identifi-
cation of glycans was based on accurate mass of doubly and
triply charged glycans with an acceptable mass deviation
(<5 ppm). In this way, TOF/MS enabled the calculation of
possible glycan compositions; however, neither the differen-
tiation between isobars as different hexoses or hexosamines
nor linkage determination was possible. MS/MS experi-
ments might allow the determination of glycan sequence by
cleavage of glycosidic bonds. However, for APTS-labeled
glycans, cross-ring cleavages are rare; hence, information
about linkage position are missing [19]. For all three applied
Table 1 Precision based on the main APTS-labeled glycans (G0F,
G1F, and G2F) of a recombinant fusion protein. Twelve analyses over
5 months were performed according to the proposed method (see Fig. 2)
using capillaries of 90 cm length
Mean RSD [%]
Relative peak ratios
G0F/G1F 1.4 5.9
G1F/G1F' 4.3 7.9
G1F/G2F 2.7 11.2
G0F/G2F 1.9 8.3
Migration time
G0F 1,575 s 3.1
G1F 1,629 s 3.8
G1F' 1,651 s 4.0
G2F 1,704 s 2.6
Resolution
G1F/G1F' 1.2 15.4
Fig. 3 Calibration plot of
APTS-labeled A1F in a range of
1.5–48 μM. The regression
curve is calculated up to 24 μM.
The second value of 24 μM
(filled square) is defined as
outlier
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biopharmaceutical products, the released APTS-labeled gly-
can pool was analyzed. Thirteen glycans were derived from
the recombinant fusion protein and seven glycans from the
cytokine product. The applied therapeutic antibody bears the
most complex glycan pool with 15 different glycan structures
including three structural isomer pairs. Therefore, as an exam-
ple, the analysis of the antibody-derived glycans is presented in
Fig. 5. The overlaid, extracted ion electropherograms of all
characterized glycans demonstrates the high resolving power
of the proposed method for complex glycan compositions of
biopharmaceutical samples. The APTS-labeled glycan pool
was in parallel analyzed by CSE-LIF (not shown). The migra-
tion order was generally reversed due to the cathodic instead of
anodic detection. All glycans determined by CSE-LIF (method
by Ruhaak et al. [29]) were found also by CE-MS as annotated
in Fig. 5. Three so far not identified glycans could be charac-
terized by CE-MS.
Application to 2-ANSA-labeled samples
As an alternative labeling reagent, 2-ANSAwas tested for IgG
glycans. As shown for 5-ANSA, this type of label is applica-
ble to HPLC, CE-LIF, and—in contrast to APTS—also to
MALDI mass spectrometry [27]. Comparing 2-ANSA and
APTS, the proposed CE-MS method with normal polarity
was employed on an IgG glycan sample in bare fused silica
capillaries of 60 cm length. The capillary length was reduced
to decrease the analysis time, while the differences in separa-
tion efficiency were still determinable. The analysis of APTS-
and 2-ANSA-labeled glycans applying the here-presented
CE-MS method is shown in Fig. 6. The comparison of these
two labels demonstrates the high potential of APTS in terms
of separation efficiency. The ion electropherograms of G0F,
G1F, and G2F glycans of IgG were extracted to ease the
comparison. Anticipated reduced separation efficiency was
demonstrated for ANSA-labeled glycans. Since, the smaller
number of sulfonic acids of 2-ANSA decreases the mobility
against the EOF and, hence, the resulting resolving power due
to a shorter migration time. Modifying the BGE in a way that
the EOF is reduced (increase of methanol (90 %) and decrease
of ammonia to 0.23 and 0.35 M in the BGE) did not improve
the separation to an extent as obtained for APTS-labeled
glycans. Alternatively, 2-ANSA-labeled samples might be
Fig. 4 Extracted ion electropherogram (EIE) of unlabeled A1F (1),
APTS-A1F (2), and desialylated APTS-A1F (3) (using the doubly,
triply, and fourfold charged glycans). a EIE of an APTS-labeled A1F
sample; b EIE of unlabeled A1F sample (48 μM A1F each). Experi-
ments were performed applying the proposed CE-MS method using a
capillary length of 90 cm (BGE as given in Fig. 2)
Table 2 The relative peak areas of unlabeled glycan standard in two
labeled samples are normalized to the separately analyzed native sam-
ple (line 1). Assuming the rest of A1F labeled, the relative labeled peak
areas are calculated (line 2). The detected peak area of APTS-labeled
A1F related to the native sample (line 3). The resulting ionization
enhancement factor for APTS-labeled glycan is shown in line 4. Ex-
periments were performed applying the proposed CE-MS method using
a capillary length of 90 cm (BGE as given in Fig. 2)
Labeled sample 1 Labeled sample 2
Area of unlabeledA1F 54 59
Expected area of labeled
A1F
46 41
Detected area of labeled
A1F
134 121
Ionization enhancement
factor
2.9 2.9
Fig. 5 EIE of the main glycans of a therapeutic antibody (using the
doubly, triply, and fourfold charged glycans). Separation was performed
with the proposed BGE system (as given in Fig. 2) using a fused silica
capillary (90 cm). Squares, N-acetylhexosamine; circles, hexose; trian-
gles, fucose; diamonds, sialic acid
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separated in acidic background electrolytes. Using an acidic
separation buffer in a CSE-LIF approach, Briggs et al. [27]
obtained an increased separation efficiency of glycans modi-
fied with single sulfonated label (5-ANSA) compared to the
application of trisulfonated APTS label.
Here, the glycan intensities were increased using the 2-
ANSA-label, explicable by higher hydrophobicity of 2-
ANSA compared to APTS increasing the ionization efficien-
cy, as described by Walker for different cationic glycan
labels [30].
Conclusion
This paper presents a novel CE-TOF-MS method with
basic background electrolyte for the analysis of APTS-
labeled glycans. The basic background electrolyte en-
abled a robust CE-MS application due to its strong
EOF, minimizing pressure and flow effects at the capil-
lary outlet. Good separation efficiency, i.e., separation of
G1F/G1F′ was obtained for biopharmaceutical samples.
The sensitivity in the low femtomole range (picomole of
sample required) is appropriate for this application. The
identification of unknown glycans for different types of
biopharmaceutically relevant proteins supports this find-
ing. A detailed and systematic study on the identification
of glycans analyzed by different CSE-LIF methods using
this proposed as well as an acidic CE-MS method will be
following soon.
The possibility to analyze APTS-labeled and charged,
native glycans simultaneously with high separation effi-
ciency is unique in this field. The proposed method enables
the determination of labeling and ionization efficiency.
Although the APTS label does not introduce hydrophobic-
ity, the ionization efficiency is a factor 3 higher than for
native glycans. In comparison to APTS-labeled glycans,
the separation efficiency for 2-ANSA-labeled glycans ap-
plying the presented method is reduced, while the ioniza-
tion efficiency was increased. Nevertheless, the proposed
method is applicable to glycans derivatized by other acidic
labels such as 2-ANSA enabling a complementary analysis
in addition to, e.g., MALDI-TOF-MS.
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Capillary Electrophoresis/Mass Spectrometry of APTS-Labeled
Glycans for the Identiﬁcation of Unknown Glycan Species in Capillary
Electrophoresis/Laser-Induced Fluorescence Systems
Svenja-Catharina Bunz,† Erdmann Rapp,‡ and Christian Neusüss*,†
†Aalen University, Aalen, 73430 Germany
‡Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany
ABSTRACT: The examination of protein glycosylation is of high importance, especially in
the (bio)pharmaceutical sector. The analysis of protein glycosylation is conducted routinely
in high performance by capillary electrophoresis with laser-induced ﬂuorescence (CE/LIF)
using 8-aminopyrene-1,3,6-trisulfonic acid (APTS)-labeled glycans. In this work we present
an optimized capillary electrophoresis/time-of-ﬂight mass spectrometry (CE/TOF-MS)
methodology for these labeled glycans, which combines the high separation performance of
CE with the high resolution, accuracy, and speed of TOF-MS for eased glycan
identiﬁcation. The system based on an acidic background electrolyte (BGE) provides a
migration direction analogue to routine CE/LIF systems. Diﬀerent BGE compositions,
capillary dimensions, coatings, and instrumental parameters were tested to optimize the
system with respect to separation eﬃciency and robustness. Subsequently, the CE/MS
method optimized for acidic conditions was compared to an alkaline CE/MS method.
Further, the mobilities of six APTS-labeled complex-type N-glycans were compared for
both CE/MS methods and two standard CE/LIF approaches. For the acidic and alkaline BGE systems, the mobilities of
sialylated glycans were shifted relative to nonsialylated glycans in comparison to common CE/LIF systems. However, in this
study a straightforward unequivocal peak assignment was achieved for all unknown glycans in a medium complex glycan mixture
from a fusion protein.
Glycosylation is one of the most abundant and complexposttranslational modiﬁcations. Many protein-based
biopharmaceuticals (e.g., monoclonal antibodies, fusion pro-
teins, or cytokines) are glycosylated. It is proven that
glycosylation inﬂuences folding, stability, and activity of
glycoproteins and thus the eﬃcacy of such biopharmaceutical
products.1 During manufacturing, the glycosylation pattern of
recombinant glycoproteins (such as monoclonal antibodies
(mAb)) may be aﬀected along up- and downstream processing
steps,2,3 as the non-template-driven posttranslational process of
glycosylation depends not only on host-cell glycosylation
machinery3 but also on cultivation conditions and the
extracellular environment (e.g., cultivation media, temperature,
aeration, pH, etc.).
Thus, the analysis and routine control during production of
glycoprotein-based drugs is mandatory. A variety of analysis
techniques exist based on intact glycoproteins, glycopeptides, or
glycans.4 The entire complexity of glycosylation (including
isomers) often requires the analysis of the glycans after cleavage
of the amino acid sequence. Therefore, diﬀerent methods
including reversed and normal phase HPLC,5 hydrophilic
interaction chromatography (HILIC),6 capillary electrophoresis
(CE),7 or high pH anion exchange chromatography (HPAEC)8
with electrochemical, optical, or mass spectrometric detection
have been reported. Among them, CE is a highly eﬃcient and
fast tool to separate structural glycan isomers in complex glycan
samples. Especially capillary sieving electrophoresis-laser-
induced ﬂuorescence detection (CSE/LIF, often referred to
as CGE-LIF (capillary gel electrophoresis-laser-induced ﬂuo-
rescence detection), a term used according to IUPAC
nomenclature9)10−13 is widespread for routine glycan analysis.
Diﬀerent systems based on pseudogel electrolytes have been
reported and applied successfully in high throughput analysis in
the pharmaceutical and food industry14 as well as in clinical
screening.12,15 The detection with ﬂuorescence requires sample
pretreatment with ﬂuorescence markers, 8-aminopyrene-1,3,6-
trisulfonic acid (APTS) being one of the most commonly
applied labels for glycans.16,17 Standard CSE/LIF approaches
for APTS-labeled glycan analysis were performed, applying a
negative potential to the capillary inlet. Thereof, two powerful
systems are based on commercial pseudogel systems.10,12,13
The methods provide high resolving power, which enables the
required separation of structural glycan isomers. However,
glycan identiﬁcation and characterization using optical
detection is initially not possible, rather only via matching
migration times (normalized to internal standards) with
database entries related to the respective glycostructures.10,12,18
A powerful alternative here is CE coupled to mass
spectrometry (MS), as it combines the high separation power
of CE with the selectivity and identiﬁcation capability of MS.
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Coupling CSE to MS is not feasible, as due to their nonvolatile
matter, common CSE electrolytes are not compatible with ESI-
MS analysis. Thus, only few CE/MS methods for glycan
analysis19 and for APTS-labeled glycans14,17,20 have been
published so far. A reliable comparison, in terms of the
separation eﬃciencies of the proposed systems, is rather
diﬃcult, as it depends on the applied type of glycans. To our
knowledge, only Gennaro et al. presented a high resolving
separation by CE/MS for APTS-labeled N-glycans of a
therapeutic antibody.17 Recently we developed an alternative
background electrolyte (BGE) system under alkaline conditions
with anodic detection by MS and high resolving power.21 To
ease the assignment of CE/MS to CSE/LIF signals, analogue
migration order is required. Thus, in this work a CE/MS
method based on an acidic background electrolyte using a
cathodic detection analogue to CSE/LIF is presented. The
method was validated for the analysis of glycans with respect to
linearity, LODs, and precision. The results were compared with
those obtained by two standard CSE/LIF methods and by the
alkaline CE/MS method.
■ MATERIALS AND METHODS
Materials. All solutions were freshly prepared using
ultrapure water (18 MΩ cm at 25 °C, SG Ultra Clear UV
from Siemens Water Technologies, Alpharetta, GA). Acetoni-
trile, methanol, and 2-propanol (each LC-MS grade), acetic
acid (p.a.), and sodium hydroxide (p.a.) were purchased from
Carl Roth GmbH and Co. KG (Karlsruhe, Germany). Citric
acid monohydrate, ε-aminocaproic acid (EACA), sodium
cyanoborohydride (NaCNBH3) in 1.0 M tetrahydrofuran, and
triethylamine, ≥99.5% (TEA) were from Sigma-Aldrich,
(Steinheim, Germany). ES Tuning mix solution was purchased
from Agilent Technologies (Waldbronn, Germany). The glycan
separation gel buﬀer (GEL1) was purchased from Beckman
Coulter (Krefeld, Germany) and the POP-7 polymer (GEL2)
from Applied Biosystems (Life Technologies Ltd., Darmstadt,
Germany). APTS-labeled glycan standards (G0F, G1F, G1F′,
G2F, A1F, and A2F; see structures in Figure 1) were supplied
from Ludger (Abingdon, UK), and APTS-labeled glycans of a
recombinant fusion protein were from Merck Serono (Rome,
Italy).
Capillaries and Coating. Diﬀerent neutral coated
capillaries with 50 μm inner diameter (i.d.) and 365 μm
outer diameter (o.d.) were investigated. Four commercial
capillaries with static coating: C-HO capillary 65 cm length
(polyvinyl alcohol (PVA) based, Beckman Coulter); eCAP
neutral capillary of 67 cm length (polyacrylamide (PAA) based,
Beckman Coulter); PVA capillary, originally length 125 cm
(used length 80−90 cm) (Agilent Technologies); Guarant of
67 cm length (Alcor Bioseparations, Palo Alto, CA). Further,
bare fused silica capillaries from Polymicro Technologies
(Phoenix, AZ/distributed by Optronis GmbH, Kehl, Germany)
were treated with the neutral dynamic UltraTrol “LN” coating
(“low normal” PAA-based precoat) from Target Discovery
(Palo Alto, CA). The coating procedure was carried out by
ﬂushing these capillaries for 15 min with precoat LN solution
and 10 min with water. Other fused silica capillaries of 90 cm
length (if not other speciﬁed) were PVA coated according to
Belder et al.22
CE. CE/MS and CE/LIF experiments were performed on a
G7100 instrument (Agilent Technologies, Waldbronn, Ger-
many) or a PA800 instrument (Beckman Coulter, Brea, CA).
For both setups, separation was performed in PVA capillaries of
90 cm length (o.d. 365 μm, i.d. 50 μm from Polymicro) at −30
kV (inlet) using a background electrolyte of 40 mM EACA, 131
mM acetic acid at a pH of 4. The capillary was ﬂushed with
water before the ﬁrst use or after storage and ﬂushed with air
for longer storage. The sample was injected hydrodynamically
applying 50 mbar for 12 s. CSE/LIF experiments were
performed applying the here-proposed acidic BGE system
and the Beckman glycan separation buﬀer (GEL1) in PVA-
coated capillaries or the POP-7 polymer (GEL2) in bare fused
silica capillaries, each of 70 cm length (eﬀective length 60.5
cm). Electrokinetic injection at −7 kV for 10 s was used for the
highly viscous GEL2.
MS. MS experiments were performed on a QTOF
instrument from Bruker Daltronik (microTOFQ, Bremen,
Germany). Electrospray ionization was used in negative ion
mode applying 4.0 kV on the MS inlet (sprayer on ground). A
nebulizer gas pressure of 0.2 mbar was applied to assist the
spraying process. For CE/MS coupling, a coaxial sheath−liquid
interface was used (CE/MS alignment interface, Agilent
Technologies). Sheath−liquid (SL) was optimized and consists
of 0.025% TEA in 2-propanol/water 1:1 (v:v). A SL ﬂow rate of
4 μL/min was used. Dry gas (nitrogen, >99.5%) was delivered
at 4.0 L/min and 170 °C. MS spectra were acquired in a mass
range of m/z 300−2500 at a repetition rate of 1 Hz
(summation of 5000 single spectra). The ion transfer was
optimized for the required mass range. An external calibration
was performed by infusing tuning mix solution at 4 μL/min
every day prior to measurements. The identiﬁcation of glycans
was based on the accurate mass of doubly and triply charged
glycans with an acceptable mass deviation (<5 ppm). Data
analysis was performed using DataAnalysis Version 4.0 from
Bruker Daltronik (Bremen, Germany). The glycan identiﬁca-
tion was veriﬁed by comparison of the isotopic mass
distribution.
LIF. The laser source was an argon ion laser (488 nm) with
an optical power of 3 mW (Beckman Coulter, Brea, CA)
applied to the PA800 CE-instrument from Beckman. The CE/
LIF/MS setup was applied to the Agilent CE-instrument as
described by Huhn et al.23 Brieﬂy, the detection of ﬂuorescence
intensity was performed with a photomultiplier system and a
detection cell from J&M Analytik AG (Aalen, Germany). A
Figure 1. Structures of all glycan standards used in this work. The
glycan structures are displayed according to CFG nomenclature. Blue
square: N-acetylgalactosamine, green circle: mannose, yellow circle:
galactose, red triangle: fucose, violet diamond: N-acetylneuraminic
acid.
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homemade capillary holder was used to place the detection cell
right on top of the sheath liquid interface. The excitation light
was absorbed by an optical ﬁlter (GG495) from Beckman
Coulter transmitting wavelengths above 512 nm.
■ RESULTS AND DISCUSSION
CE/MS Method Development. The aim was the develop-
ment of a CE/MS method comparable with standard CSE/LIF
to ease the identiﬁcation of unknown glycans. Therefore, the
same polarity (negative at inlet) was favored to obtain analogue
glycan migration order. Diﬀerent acidic systems, based on
formic acid and acetic acid, were examined. APTS-labeled
glycan samples were applied to formic acid-based BGE systems
as described by Albrecht et al.14 (3% formic acid) or a
previously presented system for sulfonic acids24 (0.2 M formic
acid). Additionally, acetic acid in diﬀerent concentrations (0.2−
0.5 M) was examined as the BGE. No satisfactory separations
were obtained (data not shown) especially when compared to
the CE/LIF/MS method published by Gennaro et al.,17 which
met all requirements with respect to separation (i.e., high
separation eﬃciency, analogue migration order by anodic
detection). However, the performance of that method (based
on a BGE of EACA) could not be reproduced in our laboratory,
especially with respect to peak shape and separation eﬃciency.
This is probably due to the pressure sensitivity inﬂuences (e.g.,
siphoning, ESI-sprayer status, and nebulizer gas ﬂow rate) as
already mentioned by Gennaro et al. Because of these ﬁndings,
the CE/LIF/MS method previously presented by Gennaro et
al.,17 had to be modiﬁed to increase performance for CE/MS
analysis of APTS-labeled glycans. So, in a ﬁrst screening, the
CE/MS parameters expected to have major impact on
separation eﬃciency and stability of the method were evaluated
in a design of experiments (DOE) and varied around the
parameters described by Gennaro et al. (i.e., 40 mM EACA at
pH 4.5 and SL of 0.2% ammonia in 2-propanol/water (1:1,
v:v)).17 An initially preformed variation of the EACA
concentration (between 20 and 80 mM) could not improve
the results (data not shown) and was not taken into account for
the DOE. The pH of the BGE (adjusted with acetic acid) and
potential addition of ammonia to the BGE were in addition to
the remaining ammonia concentration testing as well as pH and
solvent composition of the in the BGE and SL (inﬂuence on
pH), and the SL solvent composition testing (i.e., ratio of 2-
propanol to water). Finally, the nebulizer gas ﬂow and the
inﬂuence of capillary position in the CE-ESI sprayer were
examined (pressure variation). Each factor was set at two levels
as presented in Table 1. Each parameter combination and the
method of Gennaro et al. were repeated three times in
randomized order. Altogether 54 experiments were carried out
to test the diﬀerent parameter combinations (data not shown).
These experiments were performed on two commercial PVA
capillaries, applying an APTS-labeled G1F-standard (two
isomeric asialo-, biantennary complex-type N-glycans with
one galactose attached to either end of the antennae; see
structure in Figure 1).
In this DOE-driven ﬁrst screening, minor eﬀects were
observed for pH and ammonia content of BGE as well as
capillary position at the sprayer outlet. The optimal BGE was
found to be 40 mM EACA at a pH of 4 (131 mM acetic acid)
without the addition of ammonia. The nebulizer gas pressure of
0.2 bar showed signiﬁcantly higher separation eﬃciency. A 50/
50 SL composition of 2-propanol/water was more stable than
20/80. The ammonia concentration in the SL had a major
impact. On the basis of the DOE results, the main contributing
parameters (SL composition and pressure eﬀects) were studied
in detail as discussed in the following sections. Additionally, the
temperature inﬂuence turned out to be of importance and was
tested as well for diﬀerent capillary coatings.
Optimization of SL Composition. For the BGE system
based on 40 mM EACA at a pH of 4, diﬀerent SL compositions
were tested (data not shown). Diﬀerent organic solvents such
as methanol or acetonitrile decreased the ionization eﬃciency
for APTS-labeled glycans compared to 2-propanol. Thus, the
SL was composed of 2-propanol at concentrations between
20% and 50% with diﬀerent acidic (formic and acetic acid) and
basic additives (ammonia, aniline, and triethylamine (TEA)).
These experiments demonstrated that basic additives are
required to achieve good separation eﬃciency. The positively
charged amines from the SL that enter the separation capillary
from the outlet seem to enhance the separation eﬃciency,
possibly because moving ion boundaries and/or ion inter-
actions are created.25 An increase in current was observed as a
side eﬀect (i.e., from 12 μA to 22 μA in 10 min with 0.2%
ammonia in SL). However, using TEA or aniline with a stoke
radius larger than that of ammonia, and thus lower electro-
phoretic mobilities, a reduced current rise was observed (data
not shown). Finally, TEA enabled the best separation eﬃciency
in combination with a reduced current increase (only about 1.5
μA in 10 min). Thus, the optimal composition of SL was
0.025% TEA in 50% 2-propanol/water (v:v).
Inﬂuence of Pressure. The separation in this system
showed sensitivity to pressure variation on the CE, because in
CE/MS systems with no EOF the only transport mechanism is
the electromigration of ions, and pressure control at the outlet
vial is missing. Therefore, the nebulizer gas ﬂow, pressure, or
vacuum applied during the run on the inlet vial as well as
possible siphoning eﬀects can aﬀect analysis performance. The
lowest value for nebulizer gas ﬂow (0.2 bar) was found to be
best, maintaining a good and stable electrospray without
aﬀecting the separation. The inﬂuence of applying pressure or
vacuum to the capillary inlet is depicted in Figure 2; the
experiments were performed by CE/LIF on a PVA capillary of
90 cm length (Leff = 80 cm) using the described acidic BGE.
The outlet vial was ﬁlled with SL. Small pressure diﬀerences of
10 mbar have a strong eﬀect on glycan separation. Here, in CE/
LIF, the optimal value of additional pressure was found to be
−10 mbar (see Figure 2). Furthermore, it was found that the
sprayer status (i.e., corrosion or other damages on the sprayer
tip) and spray needle position may aﬀect the pressure balance
(suction eﬀect). Therefore, it is recommended to adjust the
inlet pressure to achieve the best separation eﬃciency.
Inﬂuence of Temperature. The temperature control of
CE-capillaries is diﬃcult in CE/MS experiments because the
capillary is guided out of the CE-instrument and the capillary
end (∼10 cm) is located inside the ESI sprayer. Thus, for low
Table 1. Applied Levels for Evaluating Factor Inﬂuences
factor level 1 level 2
pH of BGE (acetic acid) 4 5
ammonia concentration in BGE (mM) 0 10
SL composition (2-propanoI/water) 50/50 20/80
ammonia concentration in SL (%) 0.05 0.35
nebulizer gas pressure (bar) 0.2 0.5
capillary position at sprayer outlet lined-up 0.2 mm out
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CE-current values in MS applications (<50 μA), cooling is not
performed. However, here an inﬂuence of ambient temperature
was observed; thus, the eﬀects were studied, varying temper-
ature between 15 °C and 27.5 °C in a temperature-controlled
CE/LIF setup. The temperature values were set in random
order in a PVA-capillary of 1 m length. The reproducibility was
proven by running the 25 °C experiment twice. The migration
times of G1F shifted about 2 min per 2.5 °C as shown in Figure
3. Thus, to avoid changes in migration times, the ambient
temperature should be controlled.
Neutral Coated Capillaries. Electroosmotic backﬂow at
pH 4.0 needs to be omitted to prevent SL from entering the
CE-capillary. Therefore, diﬀerent dynamic and permanent
neutral coatings, such as PVA, PAA, and Guarant as well as a
neutral dynamic coating based on soluble PAA (“LN”), were
tested. The separations on all these neutral coated capillaries
were similar when using identical capillary lengths. For the
dynamic “LN”, a recoating every 4 runs was required while the
capillary had to be removed from MS. Permanent coating
simpliﬁes the routine analysis, but only a few suppliers provide
permanent neutral coated capillaries longer than 80 cm, which
is essential for the separation of structural glycan isomers using
the proposed method. Thus, homemade PVA-capillaries were
compared to commercial PVA-capillaries. For homemade PVA-
capillaries, no changes in migration time and eﬃciency were
observed during 36 runs. A migration time precision of 4%
(RSD) between diﬀerent PVA-coated capillaries (two commer-
cial and four homemade capillaries) was determined. Hence,
the reliability of the coating procedure and the comparability of
homemade with commercial capillaries were corroborated.
Inﬂuence of the ESI-Interface on Separation Eﬃ-
ciency. The general inﬂuence of the MS-interface was
examined by an in-line CE/LIF/MS setup. In Figure 4 the
electropherograms with LIF and MS detection of separated
APTS-labeled glycans derived from a recombinant fusion
protein are presented. The detection of G0F, G1F, and G2F
demonstrated similar peak widths and separation eﬃciency for
both detectors. Thus, in our case separation was not aﬀected by
the electrospray during the spray event. However, separation
eﬃciency is lower in CE/LIF/MS (resolution: RG1F/G1F’ = 1.1)
when compared to CE/LIF-only with SL in outlet vial
(RG1F/G1F’ = 2.5), possibly caused by the remaining pressure
eﬀects of, for example, the nebulizer gas ﬂow.
Method Validation. Under the optimal conditions in a
PVA capillary, i.e., BGE of 40 mM EACA at pH 4.0 adjusted
with acetic acid (131 mM acetic acid) and SL consisting of 50%
2-propanol and 0.025% TEA, the CE/MS method was
validated using an APTS-labeled A1F glycan standard. The
concentration of labeled A1F was calculated, taking into
account a labeling eﬃciency of 42% as determined by using
the alkaline BGE system.21 Linear regression was performed in
a range of 5−20 μM with a coeﬃcient (r) of 0.9982. An LOD
of 0.6 μM was determined for S/N of 3. Further validation
experiments are presented in the next paragraph in comparison
with an alternative alkaline system.
Comparison of Alkaline and Acidic Methods. Recently,
an alkaline BGE system for APTS-labeled and charged
(sialylated) glycans, with good results in terms of structural
isomer separation, was presented by our group.21 A BGE of 0.7
M ammonia, 0.1 M ε-aminocaproic acid in methanol/water
(7:3, v:v), a fused silica capillary of 90 cm length with cathodic
detection (+30 kV inlet), and sheath liquid of 50% 2-propanol/
water was applied.
The repeatability of the acidic and alkaline systems in
capillaries of 90 cm length was compared, applying APTS-
labeled glycans derived from a recombinant fusion protein. The
RSD of migration time and relative peak intensity for G1F as
well as the average resolution of two isomeric G1F peaks based
on the full-width-half-maximum (fwhm) were calculated by 11
replicates in the acidic and 12 replicates in the alkaline system,
respectively (data not shown). The migration time intraday
precisions were 2.6% (10.8% interday) and 3.2% (4.7%
interday) (RSDs) in the acidic and the alkaline BGE systems,
respectively. The relative peak intensity of G1F peaks showed a
intraday RSD of 6.1% (acidic, 7.1% interday) and 5.0%
(alkaline, interday 6.9%), respectively. The average resolutions
(R) of G1F isoforms were comparable in both systems (R = 1.2
(acidic) and R = 1.1 (alkaline)). On the other hand, higher
signal intensity was found for the alkaline CE/MS system
(increased peak height by a factor of 3−8). It seems that the
high percentage of methanol in the alkaline BGE supports the
ionization process. Additionally, the ionization of APTS-labeled
glycans was decreased in the acidic system due to the
Figure 2. CE/LIF electropherograms of an APTS-labeled glycan
sample of a recombinant fusion protein at diﬀerent inlet pressure
values. The proposed acidic method was applied in a PVA capillary of
90 cm length and SL in the outlet vial.
Figure 3. Overlaid CE/LIF electropherograms of an APTS-labeled
G1F standard measured at diﬀerent temperatures (the 25 °C
experiment twice). All experiments were performed in randomized
order using the proposed acidic method in a CE/LIF setup.
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requirement of basic additives in the sheath liquid (i.e., TEA).
Peak height was decreased by a factor of 3 when the TEA-
containing sheath liquid was applied to the alkaline CE/MS
system (data not shown). Nevertheless, the method was
successfully applied to characterize minor glycan species in the
recombinant fusion protein. Thirteen out of 14 peaks detected
by CSE/LIF could be identiﬁed by CE/MS, reaching down to
the 0.7% level (compared to the intensity of the main glycan).
This shows good applicability of the presented approach to
pharmaceutically relevant glycoproteins.
Comparison of Glycan Mobilities in CE/MS and CSE/
LIF Methods. As mobilities might change in CE, because of
diﬀerent BGEs (e.g., due to BGE pH and pKas of the analytes,
solvation of the analytes, BGE viscosity), a comparison between
the developed acidic and alkaline CE/MS methods and two
CSE/LIF methods (using GEL1 and GEL2) was performed
with respect to glycan mobilities. The four methods were
applied to capillaries of 70 cm length (eﬀective length 60.5 cm)
using LIF detection. The CE/MS methods were simulated via
CSE/LIF, applying SL in the outlet vial. The methods were
compared using APTS-labeled biantennary, core-fucosylated
complex-type glycans: four nonsialylated (G0F, G1F, G1F′,
G2F; see structures in Figure 1) and two sialylated (A1F, A2F;
see structures in Figure 1). The analyte’s mobilities in the acidic
BGE, GEL1, and GEL2 were determined assuming a negligible
EOF (neutral coated capillaries). For the alkaline system, the
EOF mobility was determined to be 0.015 mm2/(V s) using
rhodamine B as a neutral EOF marker (data not shown).
Figure 5 displays the mobilities in the acidic BGE, GEL2 and
alkaline BGE systems (y-coordinate) plotted against the
mobilities in GEL1 (x-coordinate). Trend lines of the
nonsialylated glycans demonstrate its linear relation. The
general mobility diﬀerences between the systems were caused
by diﬀerent BGE properties (Table 2). The lower glycan
mobilities in the alkaline BGE and GEL2 in relation to GEL1
are expected to be due to reduced analyte dissociation in
methanol and high viscosity, respectively. The higher mobilities
in the acidic BGE system are probably due to the lower
viscosity, diﬀerent analyte solvation, and/or ion interactions.
The mobilities of all tested glycans in GEL2 are proportional
to the mobilities determined in GEL1. The same is valid only
for the nonsialylated glycans when comparing the alkaline and
the acidic BGE to the GEL1, respectively. In the alkaline and to
a less extent in the acidic system, the mobilities of sialylated
glycans diﬀer from the linear behavior of the nonsialylated
glycans. Thus, peak shifts and changes in migration order of
sialylated and nonsialylated glycans are possible when CSE/LIF
and CE/MS methods are compared. However, if most glycan
species in a sample are known or the sample is not too
complex, unknown glycan peaks are expected to be assignable.
On the basis of the glycan analysis of a recombinant fusion
protein, the assignment of peaks identiﬁed by the alkaline CE/
MS method to peaks detected in CSE/LIF (GEL2) is
demonstrated (Figure 6). Linear regression is displayed for
Figure 4. LIF trace of G0F, G1F, and G2F standards (left); EIE of G0F, G1F, and G2F (right) by TOF-MS. □: N-Acetylhexosamine, ○: hexose, Δ:
fucose,◇: sialic acid. The CE/LIF/MS separation was performed on an LN capillary of 98 cm length with 40 mM EACA at pH 4 and sheath liquid
of 20% 2-propanol + 0.025% TEA.
Figure 5. Glycan mobilities of diﬀerent systems (acidic and alkaline
BGE, GEL2) are plotted against the glycan mobilities in GEL1. ■, ◆,
▲: nonsialylated glycans. □, ◇, Δ: sialylated glycans.
Table 2. BGE Properties of Common CSE/LIF Systems and
the Presented Acidic and Alkaline CE/MS Systems
POP-7
Beckman
separation
buﬀer acidic BGE
alkaline
BGE
viscosity
(mPa·s)
187 3.431 1.907 1.308
pH 10 4.5 4 10
(apparent)
coating dynamic
neutral
coated
PVA PVA fused silica
polarity reverse
(−30 kV)
reverse
(−30 kV)
reverse
(−30 kV)
normal
(+30 kV)
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the fucosylated, nonsialylated and for the fucosylated,
monosialylated glycans (four data points each), respectively.
Even though the sample contains a variety of diﬀerent glycan
structures (complex type−high mannose type, sialylated−
nonsialylated, fucosylated−nonfucosylated), all peaks identiﬁed
by CE/MS can be clearly assigned to peaks in the CSE/LIF
approach.
■ CONCLUSIONS
The developed CE/MS method with acidic BGE provides high
separation eﬃciency for APTS-labeled glycans and is applicable
for identiﬁcation of unknown glycans in CSE/LIF. Several
method parameters were examined to optimize the method’s
resolving power and robustness. For good separation eﬃciency,
a basic additive in SL is required. Capillary length of 90 cm was
best suited for structural isomer separation, independent of the
kind of neutral coating. The proposed method was tested on
CE/MS and CE/LIF. A CE/LIF/MS approach showed that
resolution is not aﬀected by the electrospray process. Pressure
variations (e.g., nebulizer gas ﬂow, capillary position, and
sprayer needle status) constituted the main inﬂuence on
separation eﬃciency and peak shape. However, ﬂow and
pressure eﬀects can be counterbalanced.
In comparison with our previously published alkaline BGE
system for APTS-labeled and charged native glycans, the
achieved ionization eﬃciency is 3−8-times lower. However, for
the alkaline BGE system, air intake during vial change was
observed using the Beckman Coulter instrument, possibly due
to the low surface tension of methanol (70%). For both CE/
MS methods, the mobilities of sialylated glycans were shifted
relative to nonsialylated glycans in comparison to common
CSE/LIF systems, as demonstrated here for biantennary, core-
fucosylated glycans. Thus, the transfer of structural peak
assignment from CE/MS to CSE/LIF may be challenging in
very complex samples. However, in this study unequivocal peak
assignment was achieved. Known glycan benchmarks or glycan
mobility databases may enable the assignment of peaks
identiﬁed by CE/MS to CSE/LIF peaks even for complex
samples.
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CSE capillary sieving electrophoresis
DOE design of experiments
EACA ε-aminocaproic acid
HPAEC high pH anion exchange chromatography
PAA polyacrylamide
PVA polyvinyl alcohol
R resolution
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31, 1274−1281.
(25) Foret, F.; Thompson, T. J.; Vouros, P.; Karger, B. L.; Gebauer,
P.; Bocek, P. Anal. Chem. 1994, 66, 4450−4458.
Analytical Chemistry Article
dx.doi.org/10.1021/ac401930j | Anal. Chem. XXXX, XXX, XXX−XXXG
 48 
 
 
Manuscripts
  
49 
0.4 Manuscript 4 
 
In-line SPE-CE-MS using a fritless bead string design – Application for 
the analysis of organic sulfonates including APTS-labeled glycans 
K. Jooß, J.Sommer, S.-C. Bunz, C. Neusüß, G. K. E. Scriba 
Electrophoresis, 2013, DOI: 10.1002/elps.201300388 
 
 
 
The manuscript presents a novel in-line SPE-CE setup. Thereby the sensitivity of the 
proposed acidic CE-MS method was increased with respect to sample concentration, to 
enable the detection of samples in the low femto-molar (fM)-range as analyzed in CE-LIF 
approaches. Applying the proposed in-line SPE-CE-MS system an enrichment factor of 
800 was obtained compared to the proposed acidic CE-MS system for the analysis of five 
APTS-labeled complex-type N-glycans. 
 
 
 
Candidate's work: Initial offline SPE experiments, project assistance, 
discussion and preparation of manuscript 
 
 50 
Manuscripts
 
51 
 
  
Electrophoresis 2013, 00, 1–8 1
Kevin Jooß
Johannes Sommer
Svenja-Catharina Bunz
Christian Neusu¨ß
Faculty of Chemistry, Aalen
University, Aalen, Germany
Received August 12, 2013
Revised October 7, 2013
Accepted October 8, 2013
Research Article
In-line SPE-CE using a fritless bead string
design—Application for the analysis of
organic sulfonates including inline
SPE-CE-MS for APTS-labeled glycans
Despite many advantages like high separation efﬁciency CE comprises the main limitation
of low concentration sensitivity, when compared to HPLC. In-line SPE is an efﬁcient
way to increase concentration sensitivity. Here, a fritless in-line-SPE-CE-MS method was
developed in order to analyze anions of strong acids. Mixed-mode (weak anion exchange
and RP) particles were used for enrichment and an acidic BGE was applied for separation.
Different particle and capillary sizes were tested. A novel bead string design with a 100 m
id column ﬁlled with particles of 90 m followed by a separation capillary with 50 m id
was easy to prepare and showed the best performance with respect to separation efﬁciency
and reproducibility. Three aromatic sulfonic acids were employed in an in-line SPE-CE-
UV approach for method development. Method validation was performed with respect to
reproducibility, robustness, and linearity. Thereafter the method was transferred to SPE-
CE-MS and applied to the analysis of glycans labeled with 8-aminopyrene-1,3,6-trisulfonic
acid. Lower limits of detection in the low nM range were achieved injecting about 10 L
of sample. This corresponds to an enrichment factor of more than 800 compared to the
corresponding CE-MS method without preconcentration.
Keywords:
CE-MS / Glycans / Inline SPE-CE / Organic sulfonates
DOI 10.1002/elps.201300388
 Additional supporting information may be found in the online version of thisarticle at the publisher’s web-site
1 Introduction
CE comprises a unique selectivity and other analytical advan-
tages like high separation efﬁciency. In addition, only a small
amount of sample and electrolyte is required, due to the small
dimensions of CE. The total volume of the capillaries does not
exceed a few micro liters and injection volumes are generally
in a range of a few tens of nanoliters (1–2% of the capillary
volume). However, this is associated with poor concentration
sensitivity, one of the major drawbacks of CE.
There are various techniques to enrich analytes, in or-
der to increase the injection volume and, thus, the concen-
tration sensitivity. Electrophoresis-based enrichment tech-
Correspondence: Dr. Christian Neusu¨ß, Faculty of Chemistry,
Aalen University, Aalen, Germany
E-mail: Christian.neusuess@htw-aalen.de
Abbreviations: ad, average diameter; APTS, 8-aminopyrene-
1,3,6-trisulfonic acid; BSA, benzenesulfonic acid; FAc, formic
acid; NSA, naphthalenesulfonic acid; TSA, p-toluenesulfonic
acid
niques, like various stacking techniques [1], transient ITP
[2] or dynamic pH-junction [3] are often easy to imple-
ment; however show limited enrichment factors especially
if used in CE-MS, where a second buffer vial is missing [4].
Chromatography-based enrichment techniques, that is, in-
line SPE enable high enrichment factors andmay additionally
be used for sample cleanup. Three general approaches to con-
struct an in-line SPE-CE system can be distinguished: (i) open
tubular columns (wall coated with SPE sorbent) [5–7] are sim-
ple to construct and allow a fast loading, due to the marginal
increase in back pressure. However, the surface and, thus,
the capacities of such devices are small. (ii) Monolithic in-line
SPE-CE capillaries contain a small section of functionalized
monolith [8–11] or membrane [12–17]. Advantages of mono-
lithic columns are the high surface area and the absence of
frits. However, a quantitative elution requires a large elution
volume, in comparison to packed beds [8]. In addition, there
are often problems with reproducibility, associated with the
process of reproducibly loading and elution [9]. (iii) Packed
Colour Online: See the article online to view Figs. 1, 3, and 5 in colour.
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beds are most commonly used in in-line SPE-CE and have
been used in many analytical applications [18–28]. There are
different approaches for the construction of a packed bed
capillary. Often frits are used to keep the SPE material in
place [21,29–35]. However, the construction of frits is an addi-
tional elaborate step and frits may lead to high backpressure
or an irreproducible EOF. In addition, frits are vulnerable
for bubble formation, disrupting the separation. Therefore,
fritless packed bed capillaries have been constructed in re-
cent years [18–20,22–27,36]. In general, the capillary consists
of three individual pieces. Between an inlet (5–10 cm, e.g.
50 m id) and a separation capillary (50–100 cm, e.g. 50 m
id), a small piece of capillary (typically 2–4 mm, with a larger
id, e.g. 150mid) contains the particles with diameters larger
than the id of the separation capillary. The joint between the
three individual capillary pieces can be accomplished by one
[20, 22–24, 26, 28] or two PTFE tubings [18, 19, 25]. Most of
these studies used an average SPE particle size of 60 m by
sieving the particles.
Mostly cations like peptides [37–39] or small molecules
[25, 28, 40] have been analyzed using in-line SPE-CE. Anions
are rarely analyzed [28]. RP-based material is most widely be-
ing used for these applications [41–45]. Many other materials
for SPE have been developed in the last years. Mixed-mode
material is especially useful for the enrichment of polar and
ionic analytes and, thus, has been applied in off-line SPE-CE
[46–48] and in-line SPE-CE [18, 23, 26]. Bunz et al. [49] used
a mixed-mode SPE material (weak anion exchange + reverse
phase properties) for off-line-SPE concentration of ethylsul-
fate and related analytes from urine prior to CE-MS analysis.
However, to our knowledge, mixed-mode sorbents have not
been applied to analyze anions by in-line SPE-CE.
CE-MS has become a broadly applied technique for the
analysis of all kinds of analytes. Recently, amethodwas devel-
oped in our group analyzing selectively the anions of strong
acids under acidic conditions [49, 50]. Similarly, glycans as
derived from proteins can be analyzed after derivatization
with 8-aminopyrene-1,3,6-trisulfonic acid (APTS) [49, 51] by
CE-MS in an acidic BGE. These approaches allow the identi-
ﬁcation of glycans from CE-LIF measurements as routinely
applied in the biopharmaceutical context [52, 53]. However,
concentration sensitivity for these APTS-labeled glycans is
about three orders of magnitude lower for CE-MS compared
to CE-LIF.
In this work, we present an in-line SPE-CE-MS method
for the analysis of anions of strong acids like APTS-labeled
glycans. Extensive experiments for the constructions, the ge-
ometries (particle, bed, and column dimensions) and the elu-
tion method have been performed in order to ﬁnd the most
easy and reproducible set-up.
2 Materials and methods
2.1 Reagents and solution
2-Propanol, formic acid (FAc), methanol (all LC-MS grade),
and aqueous ammonia (30%—p.a.) were purchased from
Carl Roth (Karlsruhe, Germany). Acetic acid (LC-MS grade)
was obtained from Fisher Scientiﬁc (Schwerte, Germany).
Triethylamine (≥ 99.5%), epsilon-aminocaproic acid (≥ 99%),
and naphtalene-2-sulfonic acid (technical, > 70%) were pur-
chased from Sigma-Aldrich (Steinheim, Germany), benzene-
sulfonic acid (BSA) and p-toluenesulfonic acid (TSA) (both
p.a.) fromFlukaAnalytical (Steinheim,Germany). TheAPTS-
labeled bi-antennary complex type glycans A1F, A2F, G0F,
G1F, and G2F were obtained from Ludger (Oxfordshire, UK)
(see structures in Supporting Information Fig. 1).
2.2 Sample preparation
BSA, p-TSA, and naphthalenesulfonic acid (NSA) were used
for the method development. Stock solutions (10 g/L) of the
sulfonic acids were obtained by dissolving each of them in
water. Stock solutions were diluted with 0.2 M FAc, to obtain
standard solutions. APTS-labeled glycans were dissolved in
water (126mg/L) to obtain a stock solution and further diluted
with water.
2.3 SPE material
Strata X-AW and Strata XL-AW, Weak Anion Mixed Mode
Materials (Phenomenex, Aschaffenburg, Germany) were
used for the construction of the in-line SPE column. Strata
X/XL-AW consists of the same porous polymer and differ
only in the beads average diameter (ad) of 30 m and 100 m
and the adsorption surface per gram (800 and 500 m2/g, re-
spectively). Other bead sizes were not available. This sorbent
is a combination of weak anion exchanger and RP material,
that is, containing repeating N-benzyl-ethylendiamine units
in the side chain of the polymer. Due to the porous carbon-
based polymer structure, the particles are soft and fragile. The
material is designed for retention of acidic compounds with a
pka-value less than 5. In order to remove interfering particle
sizes, the Strata X-AW and the Strata XL-AW were sieved,
using mesh widths of 37, 53, and 90 m (LINKER Industrie
Technik, Kassel, Germany).
2.4 CE
Separation was performed on a PA 800 plus Pharma-
ceutical Analysis System (Beckman Coulter, Brea, USA)
and a PACE/MDQ instrument (Beckman Coulter, Brea,
USA) with integrated UV-detectors. Fused silica capillar-
ies (Polymicro Technologies, Phoenix Arizona, USA) with
id of 30/50/75/100/150 m and an od of 365 m were
used for the construction of in-line SPE-CE capillaries. Sul-
fonic acids were separated in a BGE of 0.2 M FAc, APTS-
labeled glycans were separated using a BGE of 40 mM
EACA and 130 mM acetic acid [54] and capillary segments
neutrally coated with PVA, according to the protocol of
Belder et al. [55]. For separation −20 kV (organic sulfonates)
and −30 kV (APTS-labeled glycans) was applied to the
capillary inlet.
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2.5 In-line SPE-CE
An in-line-SPE-capillary consists of three individual parts of
capillary: the SPE column (∼0.4 cm) is placed between an
inlet (≈11 cm) and a separation capillary (≈70 cm) with an
id smaller than the SPE beads diameter. The capillaries are
joined by two pieces of polyvinyl chloride tubing with an id
of 190 m. In order to ﬁll the SPE column the particles were
suspended in methanol and sucked into column by vacuum
application. A straight cut of capillary ends is achieved using
rotating diamond cutter (Agilent Technologies, Waldbronn,
Germany).
Inline SPE-CE method was performed as follows:
First, the capillary was rinsed with eluent, consisting of
methanol/ammonia (30 w %) in the ratio of 95:5 v/v, in order
to remove remnants from previous analyses. For equilibra-
tion the capillary is rinsed with the respective acidic BGE,
which is similar to the off-line protocol for the SPE cartridges
[56]. Afterwards, sample was loaded on the SPE column.
Then, the capillary had to be reﬁlled and equilibrated with
the respective BGE again. Subsequently, the analytes were
eluted using a short plug of eluent. After the elution plug
was pushed over the SPE column the separation voltage was
applied. Details and optimization of these steps are described
in Section 3.2.
2.6 MS
MS was performed on the micrOTOFQ (Bruker Daltonik,
Bremen, Germany), a quadrupole TOF (QTOF-MS) equipped
with an ESI source. Coupling was performed using a coax-
ial sheath liquid interface from Agilent Technologies (Wald-
bronn,Germany); 0.025% triethylamine in isopropanol-water
(1:1, v/v) was used as sheath liquid at a ﬂow rate of 4L/ min.
The ESI source was operated in the negative mode with a pos-
itive MS inlet (4 kV) and a grounded sprayer. The ﬂow rate of
the drying gas (nitrogen,>99.5%) was 4.0 L/min at a temper-
ature of 170C. Nebulizer gas (nitrogen, >99.5%) pressure
was set to 0.2 bar. Spectra were acquired in a mass range of
400–2000 m/z at a repetition rate of 1 Hz. The instrument
was calibrated daily by infusion of ES-TOF Tuning Mix (Agi-
lent Technologies, NewCastle, Delaware, USA). The software
Data Analysis (Version 4.0 SP 2, Bruker Daltonik) was used
for data evaluation.
3 Results and discussion
3.1 Construction of in-line SPE-CE capillary
In general, two different designs of SPE-beds were con-
structed as schematically depicted in Fig. 1: A) standard de-
sign with particle ad < 1/2 × SPE columns id (type A) and B)
the bead string design with particle ad slightly smaller than
the id of the SPE column. All combination of bead and col-
umn diameter, which were evaluated are shown in Table 1.
Figure 1. Two general designs of fritless in-line SPE-CE columns:
(A) Inner diameter of the SPE column is much larger than the
SPE particles’ average diameter; (B) inner diameter of the SPE
column is slightly larger than the SPE particles’ diameter, leading
to a single bead chain.
Table 1. Different geometries of in-line SPE columns used in this
work
Particle
diameter
(m)
SPE
column id
(m)
Sep.
capillary
id (m)
Construction
typea)
Result
>37b) 50 30 B Difﬁcult to ﬁll SPE
column
Often clogged by
particles
>37b) 75 30 A Easy to ﬁll SPE column
Often clogged by
wedged particles
>37b) 100 30 A Easy to ﬁll SPE column
Often clogged by
wedged particles
>37b) 150 30 A Easy to ﬁll SPE column
Often clogged by
wedged particles
<90c) 100 50 B Good overall
performance, see
text
<90c) 150 50 B Easy to ﬁll SPE column
Low adsorption and
re-elution ability
a) Compare Fig. 2
b) Sieved from mean of 33 m.
c) >53 m, sieved from mean of 100 m.
Experiments showed, that the SPE columns of the common
packed-bead-design (Type A) bear the risk of wedged beads,
which led to clogging or formation of hollow spaces inside
the SPE columnusing the here applied porous polymer Strata
X/XL-AW material. In addition, particles hardly larger than
the id of the separation capillary easily clogged the conjunc-
tion between the SPE column and the inlet/separation capil-
lary.
Therefore, a bead string design (Type B) was applied us-
ing two different sizes (ad 100 and 33 m). Also the bead
string design capillaries with the small SPE beads (ad 33 m)
in 50 m capillaries got frequently clogged, due to particles
with similar id to the id of the separation capillary (30 m).
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Table 2. Final in-line SPE-CE method
Step Solution Volumes Pressure (mBar) Time (min)a)
1. Rinse Eluent 0.5 Vcap 1000 0.79–1.28
2. Equilibrium BGE 3 Vcap 1000 4.72–7.65
3. Load sample Sample 0.6–6 Vcap 1000 0.98–15.85
4. Reﬁll/rinse BGE 3 Vcap 1000 4.72–7.65
5. Inject eluent Eluent 0.02 Vcap 50 0.62–1.03
6. Push on SPE column BGE Vinlet + 0.5 (VSPE–Vplug) 500 0.37–0.62
7. Wait BGE – – 1
8. Push from SPE column BGE 0.22 Vcap–Vinlet + 0.5 (VSPE–Vplug) 50 2.50–4.23
9. Separation BGE – −20 kV 20
Total – – – 35.7–63.3
a) Times depending on the actual ﬂow rate.
Due to the small particle diameter the ﬁlling process was in
general more complicated and time-consuming in compari-
son to the following construction using particles of just under
90 m ad. Thus, it was waved to optimize this device.
In contrast, the bead string (Type B) capillaries with par-
ticles of just under 90 m (sieving particles with a mean of
100 m using the 90 m sieve) combined with separation
capillaries of 50 m id could be ﬁlled in seconds. Thereof,
the bead string capillaries with 150 m id SPE columns
showed low adsorption and re-elution ability in comparison to
100 m id SPE columns, which is expected to be caused by
the much higher dead volume (i.e. factor of ≈3.5 larger). For
this reason, bead string capillaries with particles just under
90min100midSPE columns combinedwith a separation
capillary of 50 m were found to be best for the construction
and, thus, used for further method development. Typically
45–55 particles were ﬁlled in a device of 4 mm length leading
to an ad of 80–85 m.
3.2 Flow rate determination
The ﬂow rate is one of the most important parameters for
method development of packed-bed inline SPE-CE capillar-
ies. Unlike standard CE capillaries, using in-line SPE capil-
laries, the ﬂow rate cannot be calculated theoretically using
the Hagen–Poiseuille equation, since the effect of the SPE
column (i.e. particle position, density of particles) on the ﬂow
conditions inside the capillary is unknown. Thus, empiri-
cal determination had to be performed: an elution plug was
injected, pressure was applied and the ﬂow rate calculated
from the time of the UV-detector signal. For CE-MS applica-
tion TSA (40 g/mL) diluted in eluent was used to determine
the ﬂow rates. It turned out, that the correlation between ﬂow
rate and applied pressure were proportional up to 500 mbar
(Supporting Information Fig. 2). From 1000 mbar, the ﬂow
rate did not increase proportionally to the applied pressure
and approached a constant ﬂow rate of about 2000 nL/min.
For a single SPE device the ﬂow rate ﬂuctuated. Over a
period of one month, the ﬂow rate (at 1000 mbar) was deter-
mined daily resulting in a RSD of 15.5 %. This is likely due
to reorganization of the particles caused by pressure varia-
tions during analysis. Thus, the ﬂow path changes, causing
different ﬂow conditions. For this reason the ﬂow rate was
determined daily.
3.3 In-line SPE-CE method
For the development and validation of the in-line SPE-CE
method, UV-detection was used. The general steps of the
in-line SPE-CE method were adapted from the off-line pro-
tocol from Jung et al. [56] and Bunz et al. [49]. However, an
additional methanol rinsing step after sample loading was
omitted here, since the methanol caused already elution of
the analytes in the in-line SPE-CE approach (elution of 88–
96%, data not shown). In Table 2 the detailed in-line SPE-CE
method is listed, including all varied parameters. Themethod
was systematically developed and optimized:
As a ﬁrst step, the in-line SPE-CE capillary was rinsed
with eluent (0.5 total capillary volumes), in order to remove
possible remnants from previous analyses. For equilibration
of the stationary phase, the capillary was rinsed with BGE (3
total capillary volumes).
The sample loading process may have inﬂuence on the
analyte adsorption process. If the loading velocity is too high,
it is possible that the analytes are not retained quantitatively.
Therefore, the loading pressure was tested at 100, 500, and
100 mbar applying identical sample volumes. Since no sig-
niﬁcant increase of signal intensities was observed by using
lower pressure settings, a pressure of 1000 mbar was used
for a short loading time.
After loading, the capillary was rinsed and reﬁlled with
BGE, in order to ﬂushnonretainingmatrix out of the capillary.
No elution was observed using the acidic BGE. Therefore, the
capillarywas thoroughly rinsedwith BGE (three total capillary
volumes).
Afterwards an elution plug with a volume of 35 nL was
injected at 50 mbar. Higher and lower elution volumes were
tested: lower volumes did not elute the analyte quantitatively;
higher volumes did not enhance the recovery. The elution
plug was pushed at 500 mbar to a position, where the center
of the elution plug and the center of the SPE column match
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(i.e. position calculated as shown in Table 2). The position
was maintained over 1 min to allow the eluent to soak into
SPE beads and to desorb the analytes. Without waiting time
the analytes could not be fully eluted. No signiﬁcant improve-
ment of the signal intensities was obtained using a waiting
time of 5 min.
Before applying voltage, the elution plug has to be placed
behind the SPE bed, as otherwise current breakdown occurs,
probably caused by bubble formation when the low conduc-
tivity elution plug resides on the SPE column. Therefore, the
elution plug has to be pushed into the capillary, before the
separation voltage was applied. The pushing step was deter-
mined empirically: First, the elution plug was pushed far into
the capillary (0.6 min at 1000 mbar), in order to ensure that
the elution plug deﬁnitely did not reside on the SPE column.
The pushing time was decreased, until the current showed
abnormal behavior or broke down. Below a pushing time of
0.3 min at 1000 mbar, the current began to ﬂuctuate and
partly broke down. This corresponded to a position about
6 cm after the SPE column. This position was transferable to
other in-line SPE-CE capillaries.
The ﬁnal in-line SPE-CE method parameters are listed
in Table 2. The resulting performance is shown in Fig. 2
based on the analysis of BSA, TSA, and NSA. The achieved
resolutionR is similar to the standardCE-UVanalysiswithout
SPE (data not shown).
3.4 Method validation
Repeatability of the optimized inline-SPE-CE-UVmethodwas
determined injecting 15 times in row the sulfonic acid stan-
dard at a concentration of 1 g/mL each. This corresponds to
Figure 2. Electropherogram of BSA, TSA (at 190 nm), and NSA
(at 224 nm) using an in-line SPE-CE-UV system. The analysis was
performed applying the optimized method (see text) injecting
1 L of standard mix (1 ng each on column)
Figure 3. Comparison of the in-line SPE-CE and a standard CE
system calculating identical injection amounts. The mean values
of the peak areas of each concentration level (three repetitions
each) are shown for BSA.
Table 3. LODs in in-line SPE-CE and standard CE for three
organic sulfonates
Substance In-line SPE-CE
LOD (ppb)
Standard CE
LOD (ppm)
Enrichment
factor
BSA 2.0 0.9 450
NSA 1.0 0.9 900
TSA 0.3 0.3 1000
a total amount of 1 ng respectively, by using a sample loading
volume of 1L. Acceptable RSD values between 3–7% for the
peak areas and 2–5% for the peak intensities were achieved.
The elution efﬁciency was tested by running the method
without rinsing equilibration and sample loading (steps 1–3
Table 2) directly after the standard method. All together six
experiments were performed on two in-line SPE capillaries.
Both capillaries delivered similar results (data not shown).
A mean of 98.3% (no value <96.7%) was eluted in the ﬁrst
of the two elution steps. This value is acceptable, especially
considering that the purpose of the in-line SPE-CE system is
to enrich analytes by a large factor.
For comparison of the calibration curve a total amount of
analytes of 0.02–1 ng were injected on a standard CE system
and the inline SPE-CE, respectively. Both systems used a sep-
aration capillary of about 70 cm in length. Six concentration
levels in a range of 2–100 ng/mL were analyzed by in-line
SPE-CE using a sample loading volume of 10 L and six cal-
ibration standards in a range of 1.5–75.5 g/mL by standard
CE using a calculated injection volume of 13.24 nL. Both, the
in-line SPE-CE system and standard CE system, showed lin-
earity in the working range for all three analytes and similar
sensitivity for same total sample amounts (see data of BSA in
Fig. 3). Assuming a correct injection calculation a mean re-
covery of 106% can be determined based on the slopes of the
calibration line. The LODs of both systems were estimated,
using the S/N ratios of the lowest concentration level. Enrich-
ment factors between 450 and 1000 (Table 3) were calculated.
The LODs of the in-line SPE-CE system, and therefore the
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Figure 4. Comparison of in-line SPE-CE-MS (+) and standard CE-
MS (x) for the analyses of the glycan A1F. Extrapolation was
performed for in-line SPE-CE-MS data up to 2500 fmol.
enrichment factors, could be further improved by increasing
the sample loading volume.
The bed capacity was determined by three repetitive
breakthrough experiments for each analyte using a concen-
tration of 20 ng/L and an injection pressure of 1000 mbar.
The mean bed capacity was between 123 and 512 ng for BSA
and NSA, respectively. These values are absolutely sufﬁcient
considering the fact that a 1 min injection of a 1 ng/L so-
lution corresponds to an amount of 10 ng. Such a 1 ng/L
solution can be measured directly by CE-UV without any
preconcentration.
Using the complete proposed protocol (including daily
ﬂow rate determination) several in-line SPE-CE devices were
used successfully over several months. Thus, the in-line SPE-
CE system is not only easy to construct but also stable to
operate over long time. If in rare cases the system instabil-
ity occurs in terms of current breakdown, the ﬂow rate is
determined again and the method functionality is restored.
3.5 APTS-labeled glycans
The aim of the following experiments was the successful
enrichment of APTS-labeled glycans using the in-line SPE-
CE, followed by TOF-MS detection. An EACA-based BGE and
a PVA-coated capillary were used (for details see Section 2.4).
APTS-labeled A1F glycan (see structure in Supporting
Information Fig. 1) was chosen for calibration. The linear-
ity was determined in a range of 250–5000 fmol applying a
50 and 500 nM standard and loading volumes of 5, 7.5, and
10 L. Good linearity was determined up to 2500 fmol. At
5000 fmol the signal intensity decreased and deviate from the
linear calibration curve (using a double logarithmic scale, see
Fig. 4). Though this linear range up to 2500 fmol is sufﬁcient
for CE-MS characterization, the bed capacity is expected to
be larger (compare BSA, TSA, NSA). However, the sample
contains a 30-fold excess of the derivatizating reagent APTS.
Figure 5. Extracted ion electropherograms of ﬁve APTS-labeled
glycans (double and triple charged species). The separation was
carried out in a PVA-coated capillary using a BGE of 40 mM EACA
and 130 mM acetic acid at −30 kV.
In order to verify the comparability of the in-line SPE-CE sys-
tem with a standard CE system, a 10 M solution of APTS-
labeled A1F was analyzed with standard CE-TOF-MS. A total
injection volume of 12.6 nL containing a total amount of
126 fmol standard was injected at 50 mbar over 12 s. The
analysis was repeated three times. The determined peak ar-
eas correspond to the expected values based on the linear re-
gression of the in-line SPE-CE system, as depicted in Fig. 4.
A 50 nM standard analyzed by in-line SPE-CE-MS delivered
equivalent peak areas as a 40 M standard using standard
CE-MS instrumentation (data not shown). This corresponds
to an enrichment factor of 800.
Subsequently, a glycan mixture containing ﬁve different
bi-antennary complex type N-glycans (A1F, A2F, G0F, G1F,
and G2F) was successfully analyzed using the inline SPE-
CE-TOF-MS system (Fig. 5). All ﬁve glycans are separated,
though not baseline separated. The resolution is similar to the
standardCE-MS analysiswithout SPE (data not shown), when
using the same capillary dimension. However, the capillary
length needs to be extended in order to separate structural
isomers as G1F and G1F′, which was shown recently using
the same separation system [54].
4 Concluding remarks
The presented novel in-line SPE-CE technique using a bead
string design provides easy and well reproducible construc-
tion as well as high recovery rates. The used mixed-mode
phase is applicable to both, organic sulfonates as well as
APTS-labeled glycans. A considerable improvement of the
detection limit could be achieved, with enrichment factors
between 450 and 1000 for three different organic sulfonates
as well as the APTS-labeled A1F glycan standard applying a
sample volume of 10 L. These enrichment factors can even
be further improved by increasing the sample loading vol-
ume. However, the overall run time of typically 45 min would
be further extended. The sensitivity of the new developed in-
line SPE-CE method was demonstrated by LOD concentra-
tions for organic sulfonates in the sub-ppb range. The in-line
C© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
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SPE-CE works in general stable and reproducible. Variations
in the ﬂow rate might occur and need to be determined reg-
ularly. A more uniform size distribution of the applied SPE
particles (using other sieves) is expected to improve ﬂow rate
stability.
The enrichment and separation of amixture of ﬁveAPTS-
labeled glycans demonstrate the potential of the presented
technique.However, the glycanmethod has to be investigated
further, in order to improve the separation and to get a better
understanding of the bed capacity with respect to an excess
of labeling reagents.
The authors have declared no conﬂict of interest.
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Chapter 3 
3 Discussion 
CSE-LIF systems are widely used for routine glycan analysis [55, 78-81]. CE-LIF 
provides high resolving power combined with highly sensitive detection. The technique is 
perfectly suited for glycan pattern analysis in complex samples. Two powerful CSE-LIF 
systems for the analysis of APTS-labeled glycans are based on commercial high viscosity 
electrolytes: the glycan gel separation buffer (further referred to as “GEL1”) from 
Beckman Coulter (Brea, US) and the Pop-7 gel (further referred to as “GEL2”) from 
Applied Biosystems (Life Technologies, UK). Their linear polymers provide an additional 
sieving effect, whereby size and shape alter the electrophoretic mobility of the charged 
analytes. Both systems provide high separation efficiency including separation of 
isomeric glycans with minor structural diversity. However, firsthand identification of 
unknown species is hardly possible. As an example, Fig. 3 depicts a CSE-LIF 
electropherogram of the APTS-labeled glycan pool derived from a recombinant fusion 
protein. The analysis was performed using the commercial GEL2 as sieving electrolyte 
and a DNA-sequencer system (method published by Ruhaak et al. [80]). The high 
separation power of CSE using GEL2 is demonstrated; however, 4 of the 15 LIF-signals 
could not be identified (by glycan standards or mobility databases). 
 
Fig. 3: CSE-LIF electropherogram of APTS-labeled glycans derived from a recombinant fusion protein. 
Unknown LIF-signals are annotated by red numbers (1-4). The analysis was performed using 
GEL2 in a fused silica capillary of 50cm length at +30 kV (method of Ruhaak et el.[80]) 
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CE-MS is a powerful tool combining the high separation efficiency of CE and the 
capability of glycan mass detection by MS. Although CE is widely used in glycan 
analysis, CE-MS methods are rare [19, 59, 75-77] (manuscript 1). The polymeric 
electrolytes of CSE are not compatible with MS detection; thus, novel CE-MS compatible 
electrolytes are required. Only few methods for APTS-labeled glycans [61, 82-85] have 
been published so far. A reliable comparison in terms of separation efficiencies of the 
published systems is rather difficult as different types of glycans were used (e.g. O-
acetylated glycans from fish serum analyzed by Jayo et al. [84]). Only Gennaro et al. 
presented a highly resolving separation by CE-MS for APTS-labeled complex type N-
glycans derived from antibodies [82]. 
This thesis proposes two highly efficient CE-MS methods for the analysis of APTS-
labeled glycans, comparable to CSE-LIF approaches, to allow the identification of 
unknown LIF signals: i) a robust system based on an alkaline BGE with cathodic 
detection (manuscript 2) and ii) an acidic CE-MS system at reverse polarity with a 
migration order analogous to standard CSE-LIF approaches (manuscript 3). Both methods 
were optimized and validated in terms of sensitivity, separation efficiency and 
reproducibility for the glycan analysis of biopharmaceutical products. Two glycan 
isomers (G1F and G1F’: two bi-antennary, core-fucosylated complex type N-glycans with 
one galactose residue linked to either of the two antennae) were used to examine the 
system’s resolving power. Additionally, the capability to identify peaks from standard 
CSE-LIF systems, i.e. mobilities of various APTS-labeled glycans, was examined. 
Therefore, the acidic and the alkaline CE-MS methods developed in this thesis and two 
CSE-LIF methods (using GEL1 and GEL2) were compared with respect to glycan 
mobilities. A full signal assignment of a biopharmaceutical sample is presented 
(manuscript 2). 
Finally, an in-line SPE-CE-MS setup was developed to increase the sensitivity in 
terms of minimal sample concentration, to enable the detection of sample in the low 
femto-molar (fM)-range as analyzed in many CE-LIF approaches.  
 
In the following paragraphs the alkaline and the acidic CE-MS method as well as 
glycan identification and peak assignment will be discussed. Furthermore, the important 
aspects of in-line SPE-CE-MS setup are addressed.  
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3.1 CE-MS Analysis: Alkaline Method 
3.1.1 Method Development and Validation 
The high performance of the previously mentioned method by Gennaro et al. was 
difficult to reproduce due to its high pressure sensitivity. In contrast, the alkaline CE-MS 
method for charged native glycans, previously published by our group [86], was robust 
for CE-MS applications due to its strong EOF. However, the performance for APTS-
labeled glycans is not satisfying (it shows broad peaks and low separation efficiency). 
Thus, the method was adapted for the use of APTS-labeled glycans resulting in a BGE of 
0.7 M ammonia, 0.1 M ε-aminocaproic acid (EACA) in 70 % (v/v) methanol/water and 
SL of 50 % (v/v) 2-propanol/water. The separation was performed in fused silica 
capillaries of 80-90 cm length with cathodic detection (+30 kV). The final method allows 
the simultaneous separation of APTS-labeled glycans as well as charged native glycans. 
Therefore, the labeling and ionization efficiency could be determined and was used to 
quantify glycans after the labeling process. The migration order is in general reversed 
compared to the standard CSE approaches. 
Method validation was performed based on four different APTS-labeled bi-antennary-
complex-type glycan standards (G0F, G1F, G1F’ and G2F, see structures Fig. 1), with 
good structural isomer separation. The method’s strong EOF facilitated the coupling of 
CE-MS and allowed a reproducible performance with good migration time precision, i.e. 
RSD of 4.7%, and appropriate resolution (R) of two isomeric G1F peaks based on the 
full-width-half-maximum (FWHM) (average R for G1F and G1F’: R = 1.1). Linearity 
was determined by an external standard calibration method in a concentration range of 
1.5-48 µM with a regression coefficient of r2 = 0.9988 (manuscript 2).  
3.1.2 Application to Biopharmaceutical Products  
The alkaline BGE system was applied to identify and characterize glycan species of 
different glycosylated biopharmaceutical products like therapeutic antibodies, fusion 
proteins or cytokines, previously analyzed by CSE-LIF. By the new method additional 
glycan species were identified. The following example presents the identification results 
of APTS-labeled glycans derived from a recombinant fusion protein (CSE-LIF results 
given in Fig. 3). Glycan identification was performed according to paragraph 3.3. The 
extracted ion electropherograms (EIEs) of all analyzed species are listed in Fig. 4. In this 
way 11 of 12 previously identified glycan species as marked in Fig. 3 were confirmed and 
all four unknown species, annotated by red numbers (1-4), were characterized. Due to the 
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low amount of sample, the last CSE-LIF signal of a tri-antennary, complex-type glycan 
was not detectable by MS. 
 
Fig. 4:  EIEs of all identified glycan species of a recombinant fusion protein applying the proposed alkaline 
CE-MS method (BGE as discussed in text, capillary length of 90 cm,). The previously unknown 
glycan species are annotated according to Fig. 3 in red numbers (1-4). Therefore, the m/z values of 
the first isotope of the doubly and triply charged glycan are summed up to one trace as annotated 
individually. 
In addition the characterized glycan compositions were verified comparing the relative 
mobilities in CSE-LIF to the CE-MS system (see manuscript 3). In this way, the identified 
glycans were clearly assigned to CE-LIF signals, despite the generally reversed migration 
order and the relatively shifted glycan mobilities.  
3.2 CE-MS Analysis: Acidic Method 
One of the first and most promising methods for CE-MS analysis of APTS-labeled 
glycans has been published by Gennaro et al. [82]. They achieved high separation 
efficiency for glycan structural isomers. Therefore, the method has shown potential to 
identify unknown glycan signals in standard CSE-LIF approaches. However, the 
published performance of this method has turned out to be difficult to reproduce. The 
main reason is most likely the sensitivity to pressure changes (i.e. by siphoning effects or 
1
2+3
4
EIE (1214.3398; 809.2241)±0.05 
EIE (1079.7711; 719.5116)±0.05
EIE (1112.8001; 741.5381)±0.05 
EIE (1133.3134; 755.2065)±0.05
EIE (1096.2950; 730.5276)±0.05 
EIE (1031.7737; 687.5134)±0.05
0
100
200
300
Intens.
0
100
200
0
1
4x10
0
500
1000
0
200
400
600
0
2
4
4x10
0 500 1000 1500 Time [s]
EIE (958.7448; 638.8270)±0.05 
EIE (950.7473; 633.4958)±0.05
EIE (1258.3479; 838.5628)±0.05 
EIE (836.6918; 557.4587)±0.05 
EIE (877.7184; 584.8098)±0.05
EIE (1177.3214; 784.5452)±0.05
EIE (1403.8956; 935.5946)±0.05
0
200
400
600
Intens.
0
2
4
4x10
0.0
0.5
4x10
0
500
1000
0
200
400
600
0
1000
0
2000
0 500 1000 1500 Time [s]
Discussion
 
63 
nebulizer gas impact), which can occur for CE-MS systems with negligible EOF (as 
already mentioned by Gennaro et al.). Alternative parameters with impact on separation 
efficiency are the BGE and SL compositions, the capillary coating as well as temperature. 
Therefore these parameters as well as the neutral capillary coating were systematically 
studied and optimized to develop a reproducible, highly efficient CE-MS method for the 
analysis of APTS-labeled glycans. 
3.2.1 Method Development: BGE Composition and Temperature Influence 
Initially different acidic BGE systems based on formiate (0.2 M and 0.8 M) and 
acetate (0.2 M - 0.5 M) were tested; however, compared to the data presented by Gennaro 
et al. these systems provide broad peak shapes and less resolving power. Consequently, 
the BGE was optimized varying the parameters used by Gennaro et al. (40 mM EACA at 
pH 4.5) i.e. the EACA concentration and the ammonia concentration in the BGE (and 
thus, pH). Finally the optimal BGE was found to be 40 mM EACA at a pH of 4.0 
(131 mM acetic acid). The experiments were performed using a capillary of 80 cm length, 
this length was found to be suitable for efficient separation of structural glycan isomers in 
complex samples. In this setup, the method provides higher resolution and better peak 
shapes compared to the previously given parameters indicated by Gennaro et al.. 
 Additionally, the influence of ambient temperature on the CE separation was studied 
and varied systematically (between 15°C and 27.5 °C) in a temperature controlled CE-
LIF setup. The migration times of APTS-labeled glycans shifted strongly, i.e. about 2 min 
per 2.5 °C. Thus, to avoid changes in migration times the ambient temperature should be 
kept constant.  
3.2.2 Sheath Liquid  
In capillary systems with little or no EOF, as the here proposed acidic CE-MS method, 
the electromigration of ionic compounds is the only transport mechanism and 
electroneutrality should be maintained [87]. The substitution of exiting counter migrating 
ions may additionally affect separation efficiency, since potential ionic interaction with 
the analyte may have an influence on separation. Experiments with and without a feed of 
counter migrating ions demonstrated: without substitution the separation efficiency 
decreases, i.e. separation of structural glycan isomers is no longer possible. In CE-MS 
systems no outlet vial with counter ions is attached, here the SL is the only ion source. 
Ions with the same charge will automatically migrate into the separation capillary to 
maintain the inner electroneutrality. In this way the separation efficiency might be 
influenced as well, since moving ionic boundaries may be created. Ionic boundaries are 
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formed when the SL ions defer from BGE ions (i.e. different mobilities). The boundaries 
between BGE and the altered electrolyte are either diffuse or sharp, dependent on the 
conductivity and mobility differences in both zones [88]. 
Under the proposed conditions at pH 4.0 EACA is positively charged (pKa: 4.4) and 
migrates out of the capillary on the inlet side. Neutral or acidic SL compositions cause a 
current decrease in the acidic EACA-based system, since the EACA ions exit the 
capillary and the BGE gets depleted. Therefore the addition of EACA to the SL in 
concentrations between 12 mM and 40 mM EACA was tested in CE-MS. However, under 
these conditions the peaks became broad and noisy. Thus, SL compositions with 
alternative basic additives such as aniline, ammonia and triethylamine (TEA) were tested 
to compensate the loss of cations. In the proposed system the positively charged amines 
enter from the SL into the capillary and migrate towards the inlet. Thereof, TEA was 
found to be best in terms of spray behavior and moderate current increase during 
separation (manuscript 3). The conductivity of the newly formed BGE differs 
significantly from the original BGE, thus a constantly increasing current profile is 
generated.  
Replacing isopropanol by alternative organic solvents, as methanol or acetonitrile, 
decreased the signal intensities. Thus, the optimal SL composition was found to be 
0.025% TEA in 50% (v/v) 2-propanol/water. The influence of the SL composition on 
separation efficiency was tested by replacing the BGE (40 mM EACA, 131 mM acetic 
acid) by SL in a CE-LIF experiment (results are shown in Fig. 5).  
 
Fig. 5:  Comparison of CE-LIF separation using the proposed acidic BGE and an outlet vial filled with 
either the same acidic BGE (red) or the optimized SL, as described in the text (black). The analysis 
was performed in row on a Beckman Coulter PA800+ instrument using the internal LIF detector 
(including an argon-ion laser source, excitation at 488nm, emission detected > 520 nm).  
Compared to the setup with BGE in the outlet vial, the migration time was reduced 
and the separation efficiency was maintained when SL was provided in the outlet vial. 
The only disadvantage using the proposed SL is the reduced sensitivity (i.e. factor of 3) 
for analytes compared to the neutral SL composition (i.e. 50% (v/v) 2-propanol/water) 
(manuscript 3).  
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3.2.3 Influence of Electrospray and Pressure Effects 
Beside the optimization of standard CE parameters, system affecting parameters were 
evaluated. In preliminary studies differences in separation efficiency and peak shape 
between CE-LIF and CE-MS within the same electrolyte system were observed. 
Therefore the influence of the electrospray process on the applied system was tested using 
an in-line CE-LIF-MS setup.  
The in-line CE-LIF-MS setup allows the combination of the highly sensitive LIF 
detection with the high resolution and accurate mass detection by MS. A CE-LIF-MS 
setup, developed in our group and recently presented by Huhn et al. [89] was applied. The 
detectors were positioned as close as possible to each other, to minimize the changes in 
migration time and peak resolution. Therefore, a homemade capillary holder was fixed 
right on top of the applied sheath flow sprayer. In this way a minimized distance of about 
12 cm between the detection units was obtained (more technical data are given in 
manuscript 2). The analytes’ signals may differ in intensity between LIF and MS, as the 
responses of the analytes change due to the different detection techniques. However, the 
in-line assembly of both detectors enables the direct peak assignment of LIF to MS 
independently from signal intensities. Therefore the setup enables a simplified 
identification of glycans.  
In this work in-line CE-LIF-MS detection was applied to evaluate the impact of the 
electrospray event on separation. The comparison of LIF and MS analysis applying the 
proposed acidic CE-MS method is shown in Fig. 6. The EIEs of four main glycan species 
of a recombinant fusion protein (G0F, G1F, G1F’ and G2F, see structures Fig. 1), are 
depicted in one electropherogram together with the corresponding LIF-trace. 
 
Fig. 6: In-line CE-LIF-MS setup applied to the acidic glycan analysis of a recombinant fusion protein. The 
LIF electropherogram of the four main glycan species (blue) was overlaid to the appropriate EIE 
generated by MS (using the doubly, triply and four-fold charged glycan masses) 
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The minor influence of the electrospray process on the systems was demonstrated, as 
the signal peak width and resolution is comparable to the in-line LIF detection. Additional 
CE-LIF-experiments showed good results with SL added to outlet vial as demonstrated in 
paragraph 3.2.2, Fig. 5. Hence, a direct impact of the electrospray process on the 
separation efficiency can be precluded.  
Subsequent experiments confirmed the pressure sensitivity of the proposed system due 
to the low inherent flow and the missing pressure control at the capillary outlet. Thus, 
even small pressure imbalances as siphoning occurrence or potential suction effects (ESI 
nebulizer) affected the separation significantly (see manuscript 3). However, these effects 
could be reduced e.g. by setting the nebulizer gas flow as low as possible to maintain a 
stable electrospray signal or adjusting the capillary inlet height to avoid siphoning. 
Furthermore the ESI-sprayer condition (i.e. corrosion effects or other damages that might 
occur at the sprayer tip) may affect the nebulizing process and thus also the resulting 
suction. In the work presented here, separation efficiencies appropriate for the 
identification of glycan species detected by CE-LIF (average resolution of two isomeric 
G1F peaks: R = 1.1) were obtained, when the described pressure influencing parameters 
were adjusted properly. However, the separation efficiency is still reduced compared to 
the CE-LIF detection with SL in the outlet vial (resolution of G1F/G1F’: R = 2.5, 
compare Fig. 5 to Fig. 7) – probably due to remaining pressure effects. The system can be 
counterbalanced by applying pressure in the low mbar range to the capillary inlet to 
increase separation efficiency. Nevertheless, system balancing by pressure was not 
followed in this work since the resolution was sufficient to assign the CE-MS signals to 
the applied CSE-LIF approach of Ruhaak (resolution of G1F/G1F’: R = 2.2). 
Furthermore, applying pressure would prolong the migration times and the required 
precise adjustment of vacuum in the low mbar range is not supported by all type of CE 
instruments (e.g. PACE/MDQ, Beckman Coulter), thus, method transfers might become 
more complicated.  
3.2.4 Capillary Coating 
The application of anodic MS-detection requires EOF prevention, since any EOF 
would be directed towards the capillary entrance, cause SL or air intake and thus would 
disturb the separation. The EOF can be suppressed by using either a BGE with a pH ≤ 2 
(most silanol groups on the capillary surface are protonated under these conditions) or 
alternatively neutral capillary coatings. As for the proposed acidic BGE system at pH 4.0 
(manuscript 2), different static neutral coatings, such as PVA, PAA and “Guarant” as well 
as a neutral dynamic coating based on soluble PAA (“LN”, low normal) were tested. The 
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capillary coatings showed similar performances when using the same capillary lengths. 
However, permanent coatings are preferred for routine analysis, since no recoating is 
necessary. Hence a commercial PVA-coated capillary was chosen due to its performance 
and availability at capillary lengths up to 125 cm. Additionally, a homemade PVA-coating 
procedure (adapted from Belder et al. [90]) was implemented alternatively to the 
commercial PVA capillaries.  
The comparability of migration times between different capillaries (two commercial 
and four homemade capillaries) was evaluated exemplarily with the two structural 
isomers of G1F. A relative standard deviation (RSD) of 4% between all capillaries 
demonstrated the reliability of the coating procedure and the comparability of homemade 
and commercial capillaries. The robustness of the capillary coatings was examined by 
CE-LIF (instead of CE-MS, to preclude any pressure influences due to missing pressure 
control at the capillary outlet). Fig. 7 shows the overlay of two electropherograms of 
APTS-labeled glycans released from a recombinant fusion protein. The samples were 
analyzed 36-times on a homemade PVA-capillary of 90 cm effective length. The shift in 
migration time between the two runs was caused by the varying ambient temperature. 
 
Fig. 7: Overlay of CE-LIF electropherograms of an APTS-labeled glycan sample from a recombinant fusion 
protein (run 1 and 36). Analysis was performed on a PVA capillary of 90 cm effective length using 
the optimized BGE in the inlet vial and SL in the outlet vial.  
It should be noted that dry storage conditions are required for the ability to reuse the 
PVA capillary after longer storage time (more than 3-4 days). Hence, the water-cleaned 
capillary was flushed with air or nitrogen at a pressure of 5 bar for 20 min to remove any 
remaining water drops from the capillary surface. Furthermore, a mixture of 50% (v/v) 
methanol/water can be used to support the drying process, without impacting the coating 
layer. 
3.2.5 Validation of the Final Method 
After the method had been established successfully and proven suitable for 
biopharmaceutical applications the method was validated. Linearity was determined by 
calibration with external standards in a concentration range of 5-20 µM with a regression 
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factor of 0.9982. A LOD of 0.6 µM was determined based on a S/N ratio of 3. The 
migration time precision was good with a RSD of 2.6% and appropriate resolution (R) of 
G1F/G1F’ (R= 1.2) for the assignment of CE-MS signals to CE-LIF. However, the 
method is not robust with respect to pressure and temperature influences, thus the precise 
adjustment and control of influencing parameters like capillary inlet height, nebulizer gas 
flow, ambient temperature and the condition of the ESI needle is required. 
3.3 Glycan Identification 
ESI-TOF-MS is well suited to characterize charged glycan species. High mass 
resolution and a fast detection enable the characterization of unknown N-glycans based 
on their accurate masses by using CE-MS. However, the technique is not capable to 
distinguish between isobaric substances as galactose and glucose. Thus, compositional 
information is limited to monomer groups like hexoses, N-acetyhexosamines or 
desoxyhexoses. In addition no structural information can be obtained firsthand.  
For the identification of target glycan structures exact masses using the possible 
charge states (doubly, triply or four-fold charged) were calculated and used to gain 
extracted ion electropherograms with a small mass deviation (±5 mDa). The calibrated 
TOF instrument enabled the determination of accurate masses with a mass deviation of 
about 5 mDa (about 5 ppm for glycan structures). The MS software (Data Analysis 4.0, 
Bruker Daltronik) created a simulated mass spectrum for the expected glycan. In cases of 
uncertainty the isotope distributions were confirmed by overlaying both spectra. The high 
resolution and accuracy of the TOF instrument is shown by the overlay of a triply 
charged, APTS-labeled bi-antennary complex-type N-glycan in Fig. 8. For [M-3H]3- the 
monoisotopic mass of 897.9120 m/z was calculated. The MS determination of the triply 
charged glycan resulted in a monoisotopic mass of 897.9196 m/z with a mass deviation of 
5.8 mDa to the theoretical mass. If necessary the mass spectra can be recalibrated using 
internal mass calibration, e.g. based on present sodium-EACA clusters or previously 
known glycans.  
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Fig. 8: Overlay of the measured mass spectrum by MS (black) and the calculated mass spectrum (red) of a 
triply charged APTS-labeled glycan  
The analysis of unknown glycan compositions is more challenging. All masses of 
peaks recognized in the base peak electropherogram are screened for possible glycan 
masses based on their m/z value and charge state. A software tool was written to calculate 
all possible glycan compositions for any potential masses of unknown glycans. The 
boundary conditions of this search were critical, as on one hand possible compositions 
should be restricted to a reasonable number but on the other hand all possible 
compositions have to be included. Therefore, the following boundaries have been set for 
the analysis of N-glycans: mass deviation ±10 mDa, charge state 2-4 and the default 
glycan monomers referred to the glycan source, based on the core-structure-monomers of 
two N-glucosamine residues linked to three mannose residues. Thereof, the software 
creates a list of all possible glycan compositions for the given masses. Thus, in most cases 
the accurate mass leads to only few potential hits, if the generic glycosylation is known. 
However, if there is no or few information about the glycosylation mechanism, an 
prediction solely by accurate mass might be not possible. Especially glycan modifications 
like sulfation and phosphorylation are difficult to distinguish (mass deviation 9 mDa). 
Additionally, different monomer combination result in similar or identical mass 
differences (e.g.: Δm (Hexose + N-Acetylneuraminic Acid) = Δm (Fucose + N-
Glucolylneuraminic Acid)).  
Furthermore, the accurate mass distances in the charge deconvoluted spectra can help 
to evaluate the existing glycan monomers, and might give a hint for structural position. 
The glycan mobility in comparison with known glycans may help to identify the right 
composition out of the proposal list as discussed in manuscript 3. Thus, all 
biopharmaceutical samples applied to the CE-MS systems proposed here could be 
identified. In addition, the identified glycan composition might be confirmed by 
fragmentation experiments via the cleavage of glycosidic bonds. However, no further 
structural information like linkage types can be obtained, since for APTS-labeled glycans 
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hardly any cross-ring fragmentation occurs [91]. Comparison with standards may finally 
confirm the identification. 
3.4 Assignment of CSE-LIF to CE-MS-signals 
The assignment of MS to LIF signals is of great importance to identify unknown 
glycan peaks in LIF, since standards are expensive or even not available. The linear 
correlation of mobilities of glycans with similar functional groups (e.g. same amount of 
sialic acids) between different BGE systems, enable the signal assignment and thus, the 
identification of CSE-LIF signals based on several known glycan species. 
A comparison between the proposed acidic and alkaline CE-MS methods and two 
CSE-LIF methods (using GEL1 and GEL2) was performed with respect to glycan 
mobilities. APTS-labeled bi-antennary, core-fucosylated complex-type glycans, thereof 
four non-sialylated and two sialylated glycans, were applied (see Fig. 9).  
 
Fig. 9: Glycan mobilities in different BGE systems (acidic and alkaline BGE, GEL2) are plotted against the 
glycan mobilities in GEL1. ■, ♦, ●: non-sialylated glycans. □, ◊, ○: sialylated glycans. 
General mobility shifts between the applied BGE systems were observed due to the 
different properties. The main impact on mobility differences may have the pH and 
viscosity. The mobilities of all tested glycans in GEL2 are proportional to the mobilities 
determined in GEL1. Comparing the alkaline and the acidic BGE to GEL1, the mobilities 
of the sialylated glycans deviate from the proportionality of non-sialylated glycans.  
Thus, the assignment of glycan peaks in the different BGE-systems might be 
challenging for glycan species of different functionality, since peak shifts and changes in 
migration order compared to the comparator system are possible. In critical cases (i.e. 
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numerous unknown signals with similar migration times) several known glycans of 
similar functionality (like same amount of sialic acids) are required to extrapolate the 
mobilities and thereby enable the assignment of peaks identified by CE-MS to CE-LIF 
peaks. This is presented based on the analysis of a recombinant fusion protein 
(electropherograms are shown in Fig. 3 and paragraph 3.3). The correlation of glycan 
mobilities in GEL2 and the alkaline BGE was studied (see manuscript 3). The used 
glycan pool included different glycan structures like complex-type or high mannose-type 
– sialylated as well as non-sialylated. However, the peaks identified by CE-MS could be 
clearly assigned to peaks in the CE-LIF approach.  
3.5 Detection Sensitivity  
The detection sensitivities of the two presented CE-MS systems differ, since the BGE 
(i.e. high concentration of methanol in the alkaline BGE) and SL compositions (i.e. basic 
TEA as additive in the acidic BGE) influence ionization efficiency as described in 
manuscript 3. Thus, higher signal intensities were found for the alkaline CE/MS system 
(peak height increased by a factor of 3-8).  
Additionally, the concentration sensitivities differ strongly between the CE-MS 
systems and the standard CSE-LIF setup which had been used for the analysis depicted in 
Fig. 3 performed on a DNA-sequencer (method published by Ruhaak et al. [80]). CE-LIF 
analysis provides high detection sensitivity due to the selective and highly efficient 
fluorescence detection for APTS-labeled glycans. The DNA-sequencer adopted for CSE-
analysis of APTS-labeled glycans showed a very high sensitivity compared to both CE-
MS systems (i.e. 1000-fold more sensitive). For CSE-LIF analysis the CE-MS samples 
were diluted 1/1000 to adjust the analyte concentrations to the dynamic range of the LIF-
detector. An in-line SPE-CE-MS concentration system may enable the analysis of 
samples previously applied to LIF-detection, as discussed in the next paragraph.  
3.6 In-line SPE-CE-MS 
The applicable sample concentrations for APTS-labeled glycans using the standard 
CE-MS systems presented in this thesis are in the low µM-range, to enable the application 
of lower concentrated samples a novel in-line SPE-CE setup for APTS-labeled glycans 
was developed based on the acidic CE-MS method. 
The in-line SPE-CE setup presents a very effective tool to overcome the drawback of 
limited concentration sensitivity in CE-MS, as it enables the increase of total injection 
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volumes from nL to µL. The method is based on a previously established off-line SPE 
method for sulfated and phosphorylated analytes [92]. The used mix-mode-phase 
consisting of weak anion exchange and a reverse phase material which had been 
employed there, was also well suited for the application to APTS-labeled glycans, as 
initial tests with APTS-labeled glycans on standard cartridges confirmed. The 
miniaturized in-line SPE construction and the corresponding method were developed 
based on sulfonic acid standards in an in-line SPE-CE-UV setup. The final setup consists 
of three capillary segments (outside diameter (od) 365 µm) fritless connected by two 
polyvinyl-chloride tubings of 190 µm inner diameter (id): i) first segment of 50 µm id and 
11 cm length (i.e. distance from inlet to SPE-column), ii) SPE-segment with a larger id of 
100 µm and 4 mm length filled with stringed SPE beads (53-90 µm od), iii) separation 
segment of 50 µm id and 70 cm length.  
This construction was used for in-line SPE-CE-MS of APTS-labeled samples 
employing the acidic CE-MS method (manuscript 4) and PVA-coated capillary segments. 
Therefore, the SPE column was conditioned with BGE and elution was performed with 
methanol/ammonia (30 w %) in the ratio of 95/5 (v/v) (detailed procedure see manuscript 
4). Finally, an enrichment factor of 800 could be calculated using a 50 nM glycan sample 
(i.e. peak area equivalent to a 40 µM sample analyzed by CE-MS without SPE). However, 
for in-line SPE-CE-MS even lower concentrated samples can be applied; the only limiting 
factor is the required injection time (injection times in the presented work: 5-10 min). 
Furthermore for APTS-labeled glycans the excess of APTS reagent should be kept as low 
as possible to avoid reducing bed-capacity (i.e. in this work sufficient linearity was shown 
up to 2.5 pmol with a 30-fold excess of APTS in solution).  
The proposed in-line SPE-CE-MS method enables the identification of APTS-labeled 
glycans in the sub-nM range, as used in CSE-LIF. Thus, the identification of low 
abundant glycan species is possible. As future aspect, the system has to be adapted to 
longer separation capillaries to exploit the high resolving power for APTS-labeled glycans 
demonstrated here. 
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Chapter 4 
4 Summary 
The aim of this work was the development of novel capillary-electrophoresis/mass 
spectrometry (CE-MS) methods with high separation power for the characterization of 8-
aminopyrene-1,3,6-trisulfonic acid (APTS)-labeled glycans derived from 
biopharmaceutical products. State of the art for routine glycan analysis is capillary sieving 
electrophoresis with laser induced fluorescence detection (CSE-LIF) using APTS as a 
fluorescence label. However, with this technique a firsthand identification of glycans is 
not possible. Therefore, CE-MS is well suited since it combines the high separation power 
of CE with the identification capabilities of mass spectrometry due to its selectivity of 
time-of-flight/mass spectrometry. However, in this field there are no reported CE-MS 
methods with good reproducibilities and separation efficiencies comparable to CSE-LIF. 
This thesis presents two high performance CE-MS methods, with appropriate 
separation efficiency (i.e. resolution of structural isomers, like G1F/G1F’) for 
biopharmaceutical samples. These include a novel method using an alkaline background 
electrolyte (BGE) and cathodic detection for the simultaneous analysis of APTS-labeled 
as well as charged native glycans. The alkaline BGE enables a robust CE-MS application 
due to the generated electroosmotic flow (EOF), thus minimizing pressure and flow 
effects at the capillary outlet. The glycans of several different types of 
biopharmaceutically relevant proteins could be identified. Furthermore, the proposed 
method enables the determination of derivatization and ionization efficiency.  
The second CE-MS method, acidic BGE, was optimized in terms of separation 
efficiency and reproducibility by investigating potential system affecting parameters (e.g. 
temperature, pressure changes, capillary positioning and coating, etc.) The developed 
method is sensitive to pressure and flow effects because the system is not stabilized by an 
EOF and pressure control at the capillary outlet is missing. Sheath liquid (SL) 
composition and pressure effects (e.g. nebulizer gas flow and siphoning effects) have the 
strongest impact on the desired high separation efficiency. For appropriate separation 
efficiency a basic additive in the SL is mandatory. Out of the tested substances, 
triethylamine was found to work best. A capillary length of 80-90 cm is required for 
structural isomer separation, with only minor significance of neutral coatings like 
polyacrylamide or polyvinyl alcohol coating used in this study. Despite its high sensitivity 
to pressure and temperature, the resulting method shows good reproducibility (in terms of 
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migration time stability and separation efficiency), since the main treats as nebulizer gas 
flow and capillary inlet height are clearly determined. Hence, pressure impacts can be 
counterbalanced by adjusting these parameters and /or applying the respective pressure 
difference to the outlet vial. 
A systematic study on the signal assignment of glycans, analyzed by two different 
CSE-LIF methods based on commercial polymers as well as using the proposed CE-MS 
methods, was performed. Standard CSE-LIF systems apply reverse polarity (anodic 
detection) like the acidic CE-MS system, in which the overall migration direction is 
reversed compared to the alkaline system using cathodic detection. The linear mobility 
correlation of glycans with similar functional groups (e.g. same amount of sialic acids) 
within the CSE-LIF and CE-MS systems allows the signal assignment and thus the 
identification of CSE-LIF signals based on several known reference glycans. The signal 
assignability of different glycan structures (like complex type – high mannose type, 
sialylated – non-sialylated), identified by the alkaline CE-MS method, to CSE-LIF was 
demonstrated based on the comparative glycan analysis of a recombinant fusion protein.  
The development of a fritless, in-line solid phase extraction (SPE) setup enables the 
injection of higher sample volumes and concomitant in-line concentration of APTS-
labeled glycans. Thus, the limit of detection of the acidic CE-MS method presented here 
could be decreased from the sub-µM-range to a low nM-range (injection time 5-10 min). 
The novel bead-string SPE design, lead to an enrichment factor of 800. Prolongation of 
injection time may further improve the concentration sensitivity. The presented method 
provides a sufficient linear range (i.e. total sample amount of 2.5 pmol using a 30-fold 
excess of APTS). 
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Chapter 5 
5 Zusammenfassung 
Ziel dieser Arbeit war die Entwicklung neuer Kapillarelektrophorese/Massen-
spektrometrie (CE-MS, capillary electrophoresis/mass spectrometry) Methoden mit hoher 
Trennleistung für die Charakterisierung von 8-Aminopyren-1,3,6-trisulfonsäure (APTS)-
markierten Glykanen biopharmazeutischer Produkte. Stand der Technik für die 
Routineanalytik von Glykanen ist die Kapillarsiebelektrophorese mit Laser induzierter 
Fluoreszenz Detektion (CSE-LIF, capillary sieving electrophoresis/laser induced 
fluorescence) unter Verwendung von APTS als Fluoreszenzmarker. Jedoch ist mit dieser 
Technik eine direkte Identifizierung der enthaltenen Glykane nicht möglich. Für diesen 
Zweck eignet sich CE-MS sehr gut, da es die hohe Trennleistung der CE mit der 
Selektivität der Massenspektrometrie verbindet. Allerdings gibt es in diesem Bereich 
keine CE-MS Methoden mit guter Reproduzierbarkeit und vergleichbar hoher 
Trennleistung wie in CSE-LIF. 
Diese Thesis präsentiert zwei CE-MS Methoden mit geeigneter Trenneffizienz, (d.h. 
Trennung von Strukturisomeren wie G1F/G1F') für die Glykananalyse von 
proteinbasierten biopharmazeutischen Produkten. Hierzu gehört eine neuartige Methode 
mit basischem Hintergrundelektrolyten (BGE, background electrolyte) und kathodischer 
Detektion für die simultane Analyse APTS-markierter, sowie geladener nativer Glykane. 
Der basische BGE ermöglicht eine robuste CE-MS Anwendung, da der generierte 
elektroosmotischem Fluss (EOF) mögliche Druck- und Strömungseinflüsse am 
Kapillarauslass verringert. Unter Verwendung dieser Methode konnten die Glykane 
verschiedener biopharmazeutisch relevanter Proteine identifiziert werden. Desweiteren 
ermöglicht die vorgestellte Methode die Bestimmung der Ionisierungs- und 
Derivatisierungseffizienz. 
Die zweite CE-MS Methode, mit saurem BGE, wurde im Hinblick auf eine hohe 
Trennleistung und guter Reproduzierbarkeit optimiert, indem mögliche 
systembeeinflussende Parameter (wie Temperatur, Druck, Kapillarpositionierung und 
Beschichtungen) untersucht wurden. Das entwickelte saure CE-MS System ist 
empfindlich gegenüber Druckeinflüssen da das System nicht über einen EOF stabilisiert 
werden kann und zudem eine Druckregulierung am Kapillarauslass fehlt. Dabei bilden die 
Zusammensetzung der Schleierflüssigkeit (SL, sheath liquid) und Druckeinflüsse (z.B. 
Vernebelungsgasstrom am Kapillarauslass und mögliche Siphoneffekte) die wichtigsten 
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Einflussfaktoren auf die gewünschte hohe Trennleistung. Für eine ausreichende 
Trennleistung sind basische Zusätze im SL von essentieller Bedeutung. Von den 
getesteten Substanzen war Triethylamin am geeignetsten. Eine Kapillarlänge von 80-
90 cm ist nötig, wenn Strukturisomere getrennt werden sollen. Dabei ist die Art der 
neutralen Kapillarbeschichtung, wie Polyacrylamid oder die hier verwendete 
Polyvinylalkohol-Beschichtung, von geringer Bedeutung. Die entwickelte Methode zeigt 
trotz ihrer Druck und Temperaturempfindlichkeit gute Wiederholpräzision (bezogen auf 
Migrationszeitstabilität und Trennleistung), da die Haupteinflussfaktoren wie 
Verneblungsgas und Kapillarhöhe am Einlass bekannt sind. Somit können Druckeinflüsse 
durch Anpassen dieser Parameter und/oder durch Anlegen des entsprechenden 
Ausgleichsdrucks am Kapillareinlass ausgeglichen werden.  
Es wurde eine systematische Untersuchung der Übertragbarkeit der Glykansignale 
zweier CSE-LIF Methoden (basierend auf zwei kommerziell erhältlichen 
Polymersystemen) auf die Signale der vorgestellten CE-MS-Methoden durchgeführt. 
Standard CSE-LIF Systeme verwenden eine anodische Detektion, wie auch die saure CE-
MS Methode, wodurch die generelle Migrationsreihenfolge umgekehrt zur basischen 
Methode mit kathodischer Detektion verläuft. Die lineare Korrelation der Mobilitäten mit 
ähnlicher Funktionalität (z.B. gleiche Anzahl an Sialinsäuren) in CSE-LIF und CE-MS 
erlaubt die Signalzuordnung und damit die Identifizierung unbekannter Signale anhand 
bekannter Glykane. Die Übertragbarkeit der Signale verschiedener Glykanstrukturen (wie 
“High Mannose” Typ – Komplexer Typ, (nicht) sialysiert – (nicht) fucosiliert), auf CE-
LIF wurde anhand der Glykananalyse eines rekombinanten Fusionsproteins mittels 
basischer CE-MS gezeigt.  
Durch die Entwicklung eines fritten-losen, in-line Festphasenextraktions- (SPE, solid 
phase extraction) Systems wurde die Injektion größerer Probenvolumina bei 
gleichzeitiger Aufkonzentrierung APTS-markierter Glykane ermöglicht. Somit konnte die 
Nachweisgrenze der sauren CE-MS Methode vom unteren µM-Bereich auf den unteren 
nM-Bereich (Injektion 5-10 min) herabgesetzt werden. Das neu entwickelte SPE-Bett mit 
einzeln aufgereihten SPE-Partikeln führte somit zu einem Anreicherungsfaktor von 800. 
Durch Erhöhung der Injektionszeiten kann die Konzentrationsempfindlichkeit weiter 
verbessert werden. Die vorgestellte Methode bietet einen ausreichenden linearen Bereich 
(d.h. Probengesamtmenge bis 2.5 pmol, bei 30-fachem APTS-Überschuss). 
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